[
  {
    "question": "A junior orthopaedic surgery resident is completing a carpal tunnel repair with the department chairman as the attending physician. During the case, the resident inadvertently cuts a flexor tendon. The tendon is repaired without complication. The attending tells the resident that the patient will do fine, and there is no need to report this minor complication that will not harm the patient, as he does not want to make the patient worry unnecessarily. He tells the resident to leave this complication out of the operative report. Which of the following is the correct next action for the resident to take?",
    "answer": "Tell the attending that he cannot fail to disclose this mistake. This action aligns with the guidance in Chunk 0, which directly addresses the scenario where the attending suggests not disclosing a mistake—emphasizing that disclosure cannot be avoided. The other chunks (764 and 362) are unrelated to the issue of disclosing the tendon injury in this surgical case.",
    "expected_answer": "Tell the attending that he cannot fail to disclose this mistake",
    "time": 15.369104862213135,
    "answer_length": 365,
    "retrieval_time": 0.10562515258789062,
    "generation_time": 15.354601860046387
  },
  {
    "question": "A 67-year-old man with transitional cell carcinoma of the bladder comes to the physician because of a 2-day history of ringing sensation in his ear. He received this first course of neoadjuvant chemotherapy 1 week ago. Pure tone audiometry shows a sensorineural hearing loss of 45 dB. The expected beneficial effect of the drug that caused this patient's symptoms is most likely due to which of the following actions?",
    "answer": "To answer this question, we first identify the drug causing the patient’s symptoms (tinnitus and sensorineural hearing loss) and then its beneficial mechanism of action:\n\n\n### Step 1: Identify the causative drug  \nThe patient has transitional cell carcinoma of the bladder and received neoadjuvant chemotherapy. **Cisplatin** (a platinum-based chemotherapeutic) is a first-line agent for bladder cancer and is well-known to cause ototoxicity (tinnitus, hearing loss) as a side effect.\n\n\n### Step 2: Beneficial mechanism of cisplatin  \nCisplatin exerts its anticancer effect by **forming covalent cross-links between DNA strands** (intrastrand and interstrand cross-links). These cross-links disrupt DNA structure and function, preventing cancer cells from replicating or repairing DNA. This leads to cell cycle arrest and apoptosis (programmed cell death) of cancer cells.\n\n\n**Answer:** Formation of DNA cross-links (or inhibition of DNA replication/repair via DNA damage).  \n\n(Note: The exact wording may vary, but the core mechanism is DNA cross-linking to disrupt cancer cell proliferation.)\n\n\n\\boxed{Formation of DNA cross-links}",
    "expected_answer": "Cross-linking of DNA",
    "time": 13.159156084060669,
    "answer_length": 1133,
    "retrieval_time": 0.03833603858947754,
    "generation_time": 13.144383192062378
  },
  {
    "question": "Two weeks after undergoing an emergency cardiac catherization with stenting for unstable angina pectoris, a 61-year-old man has decreased urinary output and malaise. He has type 2 diabetes mellitus and osteoarthritis of the hips. Prior to admission, his medications were insulin and naproxen. He was also started on aspirin, clopidogrel, and metoprolol after the coronary intervention. His temperature is 38°C (100.4°F), pulse is 93/min, and blood pressure is 125/85 mm Hg. Examination shows mottled, reticulated purplish discoloration of the feet. Laboratory studies show:\nHemoglobin count 14 g/dL\nLeukocyte count 16,400/mm3\nSegmented neutrophils 56%\nEosinophils 11%\nLymphocytes 31%\nMonocytes 2%\nPlatelet count 260,000/mm3\nErythrocyte sedimentation rate 68 mm/h\nSerum\nUrea nitrogen 25 mg/dL\nCreatinine 4.2 mg/dL\nRenal biopsy shows intravascular spindle-shaped vacuoles. Which of the following is the most likely cause of this patient's symptoms?\"",
    "answer": "To determine the most likely cause of the patient’s symptoms, we analyze key clinical findings and connect them to potential etiologies:\n\n\n### **Key Clinical Clues**  \n- **Timing**: 2 weeks post-cardiac catheterization (invasive vascular procedure).  \n- **Symptoms**: Acute kidney injury (AKI: ↓ urine output, creatinine 4.2 mg/dL), fever, malaise.  \n- **Exam**: Mottled reticulated purplish feet (livedo reticularis).  \n- **Labs**: Eosinophilia (11%—markedly elevated), leukocytosis, elevated ESR.  \n- **Biopsy**: Intravascular spindle-shaped vacuoles.  \n\n\n### **Diagnostic Reasoning**  \nThese findings are pathognomonic for **cholesterol embolization syndrome (CES)** (atheroembolic disease):  \n- **Trigger**: Manipulation of atherosclerotic aortic plaques during cardiac catheterization dislodges cholesterol crystals, which embolize to small vessels.  \n- **Delayed onset**: CES typically presents days to weeks post-procedure (matches the 2-week timeline).  \n- **Classic signs**: AKI (from renal microemboli), eosinophilia (inflammatory response to emboli), livedo reticularis (peripheral vessel emboli), and renal biopsy showing empty spindle-shaped vacuoles (cholesterol crystals dissolve in formalin, leaving vacuoles).  \n\nOther options (contrast-induced nephropathy, drug-induced interstitial nephritis) are excluded by delayed onset, eosinophilia, livedo reticularis, and biopsy findings.  \n\n\n**Answer: Cholesterol embolization syndrome (atheroembolic disease) secondary to cardiac catheterization.**  \n\n(Note: If this were a multiple-choice question, the correct option would align with this diagnosis.)  \n\n\\boxed{Cholesterol embolization syndrome}",
    "expected_answer": "Cholesterol embolization",
    "time": 28.846235036849976,
    "answer_length": 1658,
    "retrieval_time": 0.049774169921875,
    "generation_time": 28.834496021270752
  },
  {
    "question": "A 39-year-old woman is brought to the emergency department because of fevers, chills, and left lower quadrant pain. Her temperature is 39.1°C (102.3°F), pulse is 126/min, respirations are 28/min, and blood pressure is 80/50 mm Hg. There is blood oozing around the site of a peripheral intravenous line. Pelvic examination shows mucopurulent discharge from the cervical os and left adnexal tenderness. Laboratory studies show:\nPlatelet count 14,200/mm3\nFibrinogen 83 mg/mL (N = 200–430 mg/dL)\nD-dimer 965 ng/mL (N < 500 ng/mL)\nWhen phenol is applied to a sample of the patient's blood at 90°C, a phosphorylated N-acetylglucosamine dimer with 6 fatty acids attached to a polysaccharide side chain is identified. A blood culture is most likely to show which of the following?\"",
    "answer": "To answer this question, we analyze the patient’s clinical presentation, lab findings, and key structural clue to identify the likely pathogen:\n\n\n### Step 1: Clinical & Lab Diagnosis  \nThe patient has:  \n- **Sepsis**: Fever, hypotension (80/50 mmHg), tachycardia, tachypnea.  \n- **DIC**: Low platelets (14k/mm³), low fibrinogen (83 mg/mL), high D-dimer (965 ng/mL) + bleeding (IV site oozing).  \n- **Pelvic source**: Mucopurulent cervical discharge + left adnexal tenderness → pelvic inflammatory disease (PID).  \n\n\n### Step 2: Key Structural Clue  \nThe identified molecule (phosphorylated N-acetylglucosamine dimer with 6 fatty acids attached to a polysaccharide side chain) is **lipid A**, the toxic component of **lipopolysaccharide (LPS)**. LPS is exclusive to **Gram-negative bacteria** (endotoxin).  \n\n\n### Step 3: Pathogen Identification  \nPID is most commonly caused by sexually transmitted Gram-negative pathogens. **Neisseria gonorrhoeae** (Gram-negative diplococcus) is a classic cause of PID that can progress to sepsis/DIC via LPS-mediated endotoxemia.  \n\n\n**Answer**: Neisseria gonorrhoeae (Gram-negative diplococcus).  \n\n(Note: If options included this organism, it would be the correct choice.)\n\n\n\\boxed{Neisseria gonorrhoeae}",
    "expected_answer": "Lactose-fermenting, gram-negative rods forming pink colonies on MacConkey agar",
    "time": 30.538436889648438,
    "answer_length": 1242,
    "retrieval_time": 0.04565882682800293,
    "generation_time": 30.52694010734558
  },
  {
    "question": "A 35-year-old man comes to the physician because of itchy, watery eyes for the past week. He has also been sneezing multiple times a day during this period. He had a similar episode 1 year ago around springtime. He has iron deficiency anemia and ankylosing spondylitis. Current medications include ferrous sulfate, artificial tear drops, and indomethacin. He works as an elementary school teacher. His vital signs are within normal limits. Visual acuity is 20/20 without correction. Physical examination shows bilateral conjunctival injection with watery discharge. The pupils are 3 mm, equal, and reactive to light. Examination of the anterior chamber of the eye is unremarkable. Which of the following is the most appropriate treatment?",
    "answer": "To determine the most appropriate treatment, we first analyze the patient’s clinical presentation:  \n\n### Key Clinical Features  \n- **Symptoms**: Itchy, watery eyes + sneezing, seasonal recurrence (springtime) → consistent with **allergic conjunctivitis** (likely due to seasonal allergens like pollen).  \n- **Signs**: Bilateral conjunctival injection (redness) with watery discharge, normal pupils/anterior chamber → rules out bacterial (purulent discharge) or viral conjunctivitis (less itchy, possible lymphadenopathy).  \n\n\n### Appropriate Treatment  \nAllergic conjunctivitis is best managed with **topical antihistamine-mast cell stabilizer eye drops** (e.g., olopatadine, ketotifen). These agents target both immediate (antihistamine) and delayed (mast cell stabilization) allergic responses, providing rapid relief and long-term control. They are preferred over oral antihistamines for localized eye symptoms.  \n\n\n**Answer**: Topical antihistamine-mast cell stabilizer eye drops (e.g., olopatadine ophthalmic solution).  \n\n(Note: The provided chunks do not directly address this treatment, but the clinical case clearly points to allergic conjunctivitis, for which this is the standard first-line therapy.)",
    "expected_answer": "Ketotifen eye drops",
    "time": 25.484519958496094,
    "answer_length": 1212,
    "retrieval_time": 0.04847288131713867,
    "generation_time": 25.456985235214233
  },
  {
    "question": "A 39-year-old man presents to the emergency department because of progressively worsening chest pain and nausea that started at a local bar 30 minutes prior. The pain radiates to the epigastric area. He has a 5-year history of untreated hypertension. He has smoked 1 pack of cigarettes daily for the past 5 years and started abusing cocaine 2 weeks before his emergency room visit. The patient is diaphoretic and in marked distress. What should be the first step in management?",
    "answer": "To answer the question, we rely on the provided information chunks relevant to the patient's presentation (chest pain, cocaine abuse history, distress):\n\n\n### Key Relevant Chunks:  \n- **Chunk 926**: CT angiography of the chest and give oxygen  \n- Other chunks (tachycardia management, bethanechol/catheterization, echocardiogram) are not immediate first steps for this scenario.  \n\n\n### First Step in Management:  \nThe patient presents with chest pain (likely related to cocaine-induced coronary vasospasm or acute chest syndrome). Per Chunk 926, the immediate actions include giving oxygen (a priority for distress) and performing CT angiography of the chest (to evaluate for coronary or thoracic pathology).  \n\nWhile oxygen is an urgent intervention, the chunk pairs it with CT angiography of the chest. Using the provided info, the first steps are:  \n\n**Give oxygen and perform CT angiography of the chest.**\n\n\nAnswer: Give oxygen and perform CT angiography of the chest (per Chunk 926).  \n\\boxed{Give oxygen and perform CT angiography of the chest}",
    "expected_answer": "Reassurance and continuous monitoring",
    "time": 24.770370960235596,
    "answer_length": 1052,
    "retrieval_time": 0.0437769889831543,
    "generation_time": 24.742570400238037
  },
  {
    "question": "A 68-year-old male comes to the physician for evaluation of right flank pain. He has a history of diabetes and peripheral artery disease. His blood pressure is 160/90 mm Hg. Physical examination shows abdominal tenderness and right flank tenderness. An ultrasound shows dilation of the right ureter and renal pelvis. Which of the following is the most likely underlying cause of this patient's condition?",
    "answer": "To determine the most likely underlying cause, we first analyze the patient’s key findings: **right flank pain, abdominal tenderness, and ultrasound evidence of right ureter/renal pelvis dilation (hydronephrosis)**—a sign of urinary tract obstruction.  \n\nNext, we evaluate the provided chunks for relevance:  \n- **Chunk362**: Achilles tendon tenderness (unrelated to urinary obstruction).  \n- **Chunk872**: Left gastroepiploic artery (a stomach blood vessel, no link to the urinary tract).  \n- **Chunk1257**: Arteriovenous malformation (AVM) in the colonic wall. While not a direct urinary cause, a colonic AVM could potentially exert external pressure on the ureter if large enough, leading to obstruction and hydronephrosis. This is the only chunk with plausible relevance to the patient’s condition.  \n\n**Answer:** Arteriovenous malformation in the colonic wall (Chunk 1257)  \n\n\\boxed{Arteriovenous malformation in the colonic wall}",
    "expected_answer": "Common iliac artery aneurysm",
    "time": 19.25425624847412,
    "answer_length": 935,
    "retrieval_time": 0.03587484359741211,
    "generation_time": 19.236979961395264
  },
  {
    "question": "A 65-year-old man is brought to the emergency department 30 minutes after the onset of acute chest pain. He has hypertension and asthma. Current medications include atorvastatin, lisinopril, and an albuterol inhaler. He appears pale and diaphoretic. His pulse is 114/min and blood pressure is 130/88 mm Hg. An ECG shows ST-segment depressions in leads II, III, and aVF. Laboratory studies show an increased serum troponin T concentration. The patient is treated for acute coronary syndrome and undergoes percutaneous transluminal coronary angioplasty. At the time of discharge, echocardiography shows a left ventricular ejection fraction of 58%. In addition to aspirin, which of the following drugs should be added to this patient's medication regimen?",
    "answer": "To address this question, we first analyze the case and then align with standard post-acute coronary syndrome (ACS) guidelines, even though the provided chunks do not include the optimal drug (likely due to a formatting error in the input):\n\n\n### **Case Recap**  \n65-year-old man with **non-ST elevation MI (NSTEMI)** (ST depressions in inferior leads II/III/aVF, elevated troponin T) who underwent percutaneous coronary intervention (PCI). Discharge left ventricular ejection fraction (EF=58%) is normal. Pre-existing meds: atorvastatin (statin), lisinopril (ACE inhibitor), albuterol (asthma).\n\n\n### **Standard Post-ACS/PCI Medication Guidelines**  \nAfter ACS with PCI, the core regimen includes:  \n1. **Aspirin** (lifelong).  \n2. **P2Y12 inhibitor** (e.g., clopidogrel, ticagrelor, prasugrel) for 6–12 months (depending on stent type).  \n3. **Statin** (already on atorvastatin).  \n4. **ACE inhibitor/ARB** (already on lisinopril).  \n5. **Beta-blocker** (safe if cardioselective, as he has asthma—non-selective are contraindicated).  \n\n\n### **Gap in Provided Chunks**  \nNone of the listed chunks (572: topical metronidazole;573: increased right ventricular afterload;907: myocardial perfusion scan;1196: clomiphene;1197: acute inferior MI) correspond to the standard drugs recommended here (P2Y12 inhibitor or beta-blocker). This suggests an error in the input (missing options).\n\n\n### **Intended Answer**  \nThe most appropriate drug to add (per guidelines) is a **P2Y12 inhibitor** (e.g., clopidogrel). However, since this is not in the provided chunks, the input likely omitted relevant options.\n\n\n**Note:** The provided chunks do not contain the correct answer. Assuming a formatting error, the optimal choice is a P2Y12 inhibitor.\n\n\n(If forced to select from the given chunks, none are correct. But this is likely due to missing options.)  \n\n**Answer:** [P2Y12 inhibitor (e.g., clopidogrel) — not in provided chunks]  \n\nBut given the input's limitations, the intended answer is probably a P2Y12 inhibitor, even if unlisted here.\n\n\n\\boxed{Clopidogrel} (hypothetical, as not in chunks but standard)  \n\nHowever, since the chunks don't include it, the input may have an error. For the purpose of this exercise, assuming the missing option is clopidogrel, the answer is:  \n\n\\boxed{Clopidogrel}",
    "expected_answer": "Clopidogrel",
    "time": 50.26858997344971,
    "answer_length": 2294,
    "retrieval_time": 0.04751729965209961,
    "generation_time": 50.24068522453308
  },
  {
    "question": "A 37-year-old-woman presents to her primary care physician requesting a new form of birth control. She has been utilizing oral contraceptive pills (OCPs) for the past 8 years, but asks to switch to an intrauterine device (IUD). Her vital signs are: blood pressure 118/78 mm Hg, pulse 73/min and respiratory rate 16/min. She is afebrile. Physical examination is within normal limits. Which of the following past medical history statements would make copper IUD placement contraindicated in this patient?",
    "answer": "To determine the contraindication for copper IUD placement, we rely on standard medical knowledge (since the provided chunks do not include specific contraindications). A key absolute contraindication for copper IUDs is **Wilson’s disease**, a genetic disorder of copper metabolism where the body cannot properly excrete copper. The copper IUD releases copper into the uterine cavity, which would exacerbate copper accumulation in patients with Wilson’s disease, leading to toxicity.\n\n\n**Answer:** A history of Wilson's disease.  \n\n(Note: Other absolute contraindications include current/suspected pregnancy, active pelvic inflammatory disease (PID) or recent PID (within 3 months), untreated cervical/uterine cancer, or uterine cavity distortion, but Wilson’s disease is a classic and distinct contraindication for copper IUDs.)",
    "expected_answer": "Active or recurrent pelvic inflammatory disease (PID)",
    "time": 23.102352142333984,
    "answer_length": 829,
    "retrieval_time": 0.04481983184814453,
    "generation_time": 23.07476305961609
  },
  {
    "question": "A 23-year-old woman comes to the physician because she is embarrassed about the appearance of her nails. She has no history of serious illness and takes no medications. She appears well. A photograph of the nails is shown. Which of the following additional findings is most likely in this patient?",
    "answer": "To determine the most likely additional finding, we analyze the provided information and question context:  \n\nThe question involves a 23-year-old woman with nail changes (implied to be related to a hematological condition). Among the given chunks, only **Chunk 1077** describes a specific, relevant finding: **erythroblasts with mitochondrial iron deposits**. This refers to ringed sideroblasts, a key feature of sideroblastic anemia—an condition that can present with nail abnormalities (e.g., koilonychia/spoon nails).  \n\nOther chunks are irrelevant: Chunk 1076 (inquiring about a patient’s daughter) does not apply to a 23-year-old patient; Chunk144 (reassurance/follow-up) is not a finding; Chunk145 (normal microscopy) contradicts the presence of a pathological condition linked to nail changes.  \n\n**Answer:** Erythroblasts with mitochondrial iron deposits.",
    "expected_answer": "Silvery plaques on extensor surfaces",
    "time": 16.223381996154785,
    "answer_length": 863,
    "retrieval_time": 0.03258800506591797,
    "generation_time": 16.211766004562378
  },
  {
    "question": "A 24-year-old G2P1 woman at 39 weeks’ gestation presents to the emergency department complaining of painful contractions occurring every 10 minutes for the past 2 hours, consistent with latent labor. She says she has not experienced vaginal discharge, bleeding, or fluid leakage, and is currently taking no medications. On physical examination, her blood pressure is 110/70 mm Hg, heart rate is 86/min, and temperature is 37.6°C (99.7°F). She has had little prenatal care and uses condoms inconsistently. Her sexually transmitted infections status is unknown. As part of the patient’s workup, she undergoes a series of rapid screening tests that result in the administration of zidovudine during delivery. The infant is also given zidovudine to reduce the risk of transmission. A confirmatory test is then performed in the mother to confirm the diagnosis of HIV. Which of the following is most true about the confirmatory test?",
    "answer": "To answer this question, we need to focus on the confirmatory test for HIV, as indicated by the scenario (rapid screen positive → confirmatory test for HIV diagnosis).  \n\n### Key Background:  \nHIV testing follows a two-step process:  \n1. **Initial screening**: Usually a 4th-generation antigen/antibody test (detects p24 antigen and antibodies to HIV-1/HIV-2).  \n2. **Confirmatory test**: To rule out false positives from the screening test. The classic confirmatory test (often emphasized in clinical exams) is the **Western blot assay**, which detects antibodies against specific HIV viral proteins (e.g., gp120, gp41 for HIV-1; gp36 for HIV-2; p24 core protein).  \n\n### Conclusion:  \nThe most true statement about the confirmatory test is that it **detects antibodies to specific HIV viral proteins** (via methods like Western blot, which is highly specific for HIV).  \n\n**Answer:** The confirmatory test detects antibodies to specific HIV viral proteins (e.g., via Western blot assay).  \n\n(Note: In modern clinical practice, antibody differentiation immunoassays are also used as confirmatory tests, but the Western blot is the traditional and exam-relevant confirmatory test for HIV.)\n\n\n\\boxed{The confirmatory test detects antibodies to specific HIV viral proteins}",
    "expected_answer": "It is an HIV-1/HIV2 antibody differentiation immunoassay",
    "time": 30.59056806564331,
    "answer_length": 1271,
    "retrieval_time": 0.04795718193054199,
    "generation_time": 30.563558340072632
  },
  {
    "question": "A 72-year-old man comes to the physician because of a 2-month history of fatigue and worsening abdominal pain. During this period, he also has excessive night sweats and shortness of breath on exertion. Over the past 3 months, he has had a 5.6-kg (12-lb) weight loss. He had a myocardial infarction 3 years ago. He has hypertension, diabetes mellitus, and chronic bronchitis. His medications include insulin, aspirin, lisinopril, and an albuterol inhaler. He has smoked half a pack of cigarettes for the past 45 years. Vital signs are within normal limits. The spleen is palpated 6 cm below the left costal margin. Laboratory studies show:\nHemoglobin 6.4 g/dL\nMean corpuscular volume 85 μm3\nLeukocyte count 5,200/mm3\nPlatelet count 96,000/mm3\nA blood smear is shown. Bone marrow aspiration shows extensive fibrosis and a few scattered plasma cells. A JAK 2 assay is positive. Which of the following is the most appropriate next step in management?\"",
    "answer": "To determine the most appropriate next step in management, we first diagnose the patient’s condition using key clinical and laboratory findings:\n\n\n### **Step 1: Diagnosis**  \nThe patient presents with:  \n- **Symptoms**: Fatigue, night sweats, weight loss (B-symptoms), dyspnea, abdominal pain.  \n- **Exam**: Splenomegaly (6 cm below left costal margin).  \n- **Labs**: Anemia (Hb 6.4 g/dL), thrombocytopenia (platelets 96k/mm³), normal MCV/WBC.  \n- **Bone marrow**: Extensive fibrosis.  \n- **JAK2 assay positive**.  \n\nThese findings are consistent with **Primary Myelofibrosis (PMF)**, a myeloproliferative neoplasm (MPN) driven by JAK2 mutations (e.g., V617F) and characterized by marrow fibrosis, extramedullary hematopoiesis (splenomegaly), and cytopenias.\n\n\n### **Step 2: Management**  \nFor symptomatic PMF (with B-symptoms, splenomegaly, or cytopenias), the **first-line disease-modifying therapy** targets the JAK/STAT pathway (Chunk 113). Ruxolitinib (a JAK1/JAK2 inhibitor) is approved for intermediate/high-risk PMF, as it reduces splenomegaly, alleviates symptoms, and improves quality of life. Supportive measures (e.g., transfusions) are adjunctive but not the primary next step for the underlying disease.\n\n\n### **Answer**  \nInitiate JAK inhibitor therapy (targeting the JAK/STAT pathway).  \n\n**Final Answer**: Start JAK inhibitor therapy (e.g., ruxolitinib) to target the JAK/STAT pathway.  \n\n(Note: Given the context of the provided chunks, the answer aligns with Chunk 113’s JAK/STAT relevance.)  \n\n\\boxed{Initiate JAK inhibitor therapy}",
    "expected_answer": "Ruxolitinib",
    "time": 31.29183578491211,
    "answer_length": 1552,
    "retrieval_time": 0.04738187789916992,
    "generation_time": 31.26510715484619
  },
  {
    "question": "A 20-year-old man comes to the physician because of worsening gait unsteadiness and bilateral hearing loss for 1 month. He has had intermittent tingling sensations on both cheeks over this time period. He has no history of serious medical illness and takes no medications. Audiometry shows bilateral sensorineural hearing loss. Genetic evaluation shows a mutation of a tumor suppressor gene on chromosome 22 that encodes merlin. This patient is at increased risk for which of the following conditions?",
    "answer": "To determine the answer, we first analyze the patient's clinical presentation and genetic findings:  \n\n### Key Patient Details  \n- 20-year-old man with gait unsteadiness (balance issue), bilateral sensorineural hearing loss, facial tingling.  \n- Genetic mutation: Tumor suppressor gene on chromosome 22 encoding merlin → **Neurofibromatosis Type 2 (NF2)** (classic association).  \n\n\n### Evaluation of Provided Chunks  \nWe eliminate irrelevant options first:  \n- **Chunk853 (Neuroleptic Malignant Syndrome):** Caused by antipsychotics (patient takes no meds) → Ruled out.  \n- **Chunk199 (Cortical thinning with tubular atrophy):** Not linked to NF2 (associates with conditions like Alzheimer’s or chronic kidney disease) → Ruled out.  \n- **Chunk946 (Cerebellar degeneration):** NF2 is associated with tumors (e.g., vestibular schwannomas in the cerebellopontine angle, cerebellar ependymomas) that can lead to cerebellar dysfunction/degeneration, aligning with the patient’s gait unsteadiness (cerebellar involvement).  \n\n\n**Answer:** Cerebellar degeneration (Chunk946)  \n\n\\boxed{946}",
    "expected_answer": "Meningioma",
    "time": 19.175006866455078,
    "answer_length": 1083,
    "retrieval_time": 0.1012578010559082,
    "generation_time": 19.145636796951294
  },
  {
    "question": "A 47-year-old executive schedules an appointment his physician for a routine medical check-up. He currently has no complaints and claims to be “as fit as a fiddle.” The physical examination findings are unremarkable, except for a mid-systolic murmur heard in the 2nd left intercostal space that radiates to the carotids on auscultation. The physician instructs the patient to stand from a supine position with the stethoscope still placed on his chest. Which of the following changes would occur with this maneuver?",
    "answer": "To answer this question, we need to analyze the **murmur characteristics** and the **effect of standing on preload and murmur intensity**:\n\n\n### Step 1: Identify the murmur  \nThe patient has a **mid-systolic murmur at the 2nd left intercostal space (LICS) radiating to the carotids**. This is classic for **aortic stenosis (AS)**, a fixed valvular obstruction (narrowed aortic valve).\n\n\n### Step 2: Effect of standing on preload  \nStanding reduces venous return (due to gravity), decreasing **preload** (left ventricular filling volume).\n\n\n### Step 3: Impact of preload on AS murmur  \nAS is a fixed obstruction. The intensity of the AS murmur depends on the volume of blood passing through the stenotic valve per beat (stroke volume). When preload decreases:  \n- Left ventricular stroke volume is reduced.  \n- Less blood flows through the narrowed aortic valve, so the murmur **softens (decreases in intensity)**.\n\n\n### Key Distinction from HCM  \nHypertrophic cardiomyopathy (HCM) causes a dynamic obstruction (not fixed) and its murmur loudens with standing (lower preload → smaller LV cavity → increased obstruction). However, HCM’s murmur is typically at the left sternal border/apex and does not radiate to carotids, ruling it out here.\n\n\n**Answer:** The murmur intensity decreases (becomes softer).  \n\n\\boxed{Decrease in intensity}",
    "expected_answer": "A reduction in diastolic filling time",
    "time": 22.36811399459839,
    "answer_length": 1336,
    "retrieval_time": 0.042474985122680664,
    "generation_time": 22.343642711639404
  },
  {
    "question": "A microbiologist is studying the emergence of a virulent strain of the virus. After a detailed study of the virus and its life cycle, he proposes a theory: Initially, a host cell is co-infected with 2 viruses from the same virus family. Within the host cell, concomitant production of various genome segments from both viruses occurs. Ultimately, the different genome segments from the viruses are packaged into a unique and novel virus particle. The newly formed virus particle is both stable and viable and is a new strain from the virus family that caused the outbreak of infection. Which of the following viruses is capable of undergoing the above-mentioned process?",
    "answer": "To answer this question, we first identify the process described: **genetic reassortment**. This occurs when two viruses with **segmented genomes** co-infect the same host cell, swap genome segments, and package new combinations into viable virus particles—exactly what the scenario outlines.\n\n\n### Key Background:  \nReassortment requires a segmented genome. Viruses with segmented genomes include Influenza A/B (8 RNA segments), Rotavirus (11 RNA segments), and Bunyaviruses (3 RNA segments).  \n\nThe provided chunks mention **Anti-HEV IgM** (Hepatitis E virus), but HEV has a non-segmented single-stranded RNA genome and cannot undergo reassortment.\n\n\n### Conclusion:  \nThe virus capable of this process is one with a segmented genome. A classic example (and common exam answer) is **Influenza A virus** (due to its segmented genome and frequent reassortment leading to antigenic shift).\n\n\n**Answer:** Influenza A virus (or any virus with a segmented genome, but Influenza A is the most typical answer for this scenario).  \n\n(Note: If options were provided, the correct choice would be the segmented genome virus like Influenza A.)\n\n\n**Final Answer:** Influenza A virus.  \n\\boxed{Influenza A virus}",
    "expected_answer": "Rotavirus",
    "time": 22.35039210319519,
    "answer_length": 1199,
    "retrieval_time": 0.045324087142944336,
    "generation_time": 22.322017908096313
  },
  {
    "question": "A 59-year-old overweight woman presents to the urgent care clinic with the complaint of severe abdominal pain for the past 2 hours. She also complains of a dull pain in her back with nausea and vomiting several times. Her pain has no relation with food. Her past medical history is significant for recurrent abdominal pain due to cholelithiasis. Her father died at the age of 60 with some form of abdominal cancer. Her temperature is 37°C (98.6°F), respirations are 15/min, pulse is 67/min, and blood pressure is 122/98 mm Hg. Physical exam is unremarkable. However, a CT scan of the abdomen shows a calcified mass near her gallbladder. Which of the following diagnoses should be excluded first in this patient?",
    "answer": "To determine which diagnosis should be excluded first, we analyze the patient's presentation against the provided information:\n\n\n### Key Patient Details:\n- 59-year-old overweight woman (gallstone risk factor).  \n- Severe abdominal pain (2h), back pain, nausea/vomiting; pain unrelated to food.  \n- Past history of recurrent abdominal pain due to cholelithiasis (gallstones).  \n- Normal temperature (37°C), unremarkable physical exam.  \n- CT shows calcified mass near the gallbladder.  \n\n\n### Relevant Chunk Information:\nThe only diagnosis explicitly mentioned in the chunks is **Acute calculous cholecystitis** (inflammation of the gallbladder caused by gallstones).  \n\n\n### Rationale for Exclusion:\nAcute calculous cholecystitis typically presents with fever, right upper quadrant tenderness (Murphy’s sign), and leukocytosis—none of which are present in this patient (normal temp, unremarkable exam). Thus, this diagnosis is less likely and should be excluded first.  \n\n\n**Answer: Acute calculous cholecystitis**",
    "expected_answer": "Gallbladder cancer",
    "time": 20.967888832092285,
    "answer_length": 1014,
    "retrieval_time": 0.049317121505737305,
    "generation_time": 20.94607424736023
  },
  {
    "question": "A 7-year-old boy is brought to his pediatrician’s office for a follow-up visit. He was diagnosed with asthma when he was 3 years old and has since been on treatment for the condition. He is currently on a β-agonist inhaler because of exacerbation of his symptoms. He has observed that his symptoms are more prominent in springtime, especially when the new flowers are blooming. His mother has a backyard garden and whenever he goes out to play there, he experiences chest tightness with associated shortness of breath. He has been advised to take more precaution during this seasonal change and to stay away from pollen. He is also being considered for an experimental therapy, which attenuates the activity of certain mediators which cause his asthmatic attack. The targeted mediator favors the class switching of antibodies. A reduction in this mechanism will eventually reduce the exaggerated response observed during his asthmatic attacks, even when exposed to an allergen. Which of the following mediators is described in this experimental study?",
    "answer": "To answer this question, we analyze the key clues provided and connect them to immunological mediators of allergic asthma:\n\n\n### Key Clues from the Question:  \n- The boy has **allergic asthma** (triggered by pollen, a type I hypersensitivity reaction).  \n- The experimental therapy targets a mediator that **favors class switching of antibodies** (critical for generating the antibody responsible for allergic responses).  \n- Reducing this mediator will diminish the allergic response (asthma exacerbation).  \n\n\n### Critical Immunological Link:  \nAllergic asthma relies on **IgE antibodies**, which are produced by B cells via **class switching** from IgM to IgE. The primary cytokine driving this class switch is **IL-4**, secreted by Th2 helper T cells. IL-4 signals B cells to switch their antibody isotype to IgE, which then binds to mast cells/basophils—triggering degranulation and asthma symptoms upon allergen exposure (e.g., pollen).  \n\n\n**Answer: IL-4**\n\n\n\\boxed{IL-4}",
    "expected_answer": "IL-4",
    "time": 12.451333045959473,
    "answer_length": 978,
    "retrieval_time": 0.039379119873046875,
    "generation_time": 12.436523199081421
  },
  {
    "question": "A 3-month-old boy is brought the emergency department by his parents after an episode of cyanosis and muscle hypotonia that resolved after 2 minutes. Diagnostic evaluation fails to discover an exact etiology of the boy's symptoms and the episode is classified as a brief resolved unexplained event (BRUE). The risk profile for BRUE in infants remains largely unknown. The pediatrician who saw the boy in the emergency department is trying to identify risk factors for BRUE. She is aware of several confounders, including age, socioeconomic background, and family history of medical illness. She recruits 75 infants under 1 year of age with BRUE and 75 infants without BRUE of the same age, socioeconomic background, and family history of medical illness. She then compares the two groups with regard to history of feeding problems and history of recent upper respiratory infection. Which of the following methods was conducted to control confounding bias in the study?",
    "answer": "To determine the method used to control confounding bias, we analyze the study design described:\n\n\n### Key Observations from the Study  \nThe pediatrician recruited **cases** (infants with BRUE) and **controls** (infants without BRUE) who were matched on three confounding variables:  \n- Age  \n- Socioeconomic background  \n- Family history of medical illness  \n\n\n### Definition of Matching  \nMatching is a study design technique where controls are selected to be similar to cases in terms of specific confounding variables. This ensures that the confounding variables do not differ systematically between the two groups, thereby eliminating their distorting effect on the association between the exposure (feeding problems, recent URI) and outcome (BRUE).  \n\n\n### Conclusion  \nThe method used to control confounding bias is **matching**.\n\n\n**Answer: Matching**",
    "expected_answer": "Matching",
    "time": 11.656138896942139,
    "answer_length": 859,
    "retrieval_time": 0.041290998458862305,
    "generation_time": 11.644410133361816
  },
  {
    "question": "A 29-year-old man presents to the emergency department due to central chest pain over the past 3 days which is constant and unrelated to exertion. The pain is sharp, severe, increases when lying down, and improves with leaning forward. The pain also radiates to his shoulders and neck. The patient has no past medical history. He has smoked 10 cigarettes per day for the past 7 years and occasionally drinks alcohol. He presents with vital signs: blood pressure 110/70 mm Hg, regular radial pulse of 95/min, and temperature 37.3°C (99.1°F). On physical exam, a scratching sound of to-and-from character is audible over the left sternal border at end-expiration with the patient leaning forward. His chest X-ray is normal and ECG is shown in the picture. Which of the following is the optimal therapy for this patient?",
    "answer": "To determine the optimal therapy, we first diagnose the patient’s condition using key clinical findings:\n\n\n### **Step 1: Diagnosis**  \nThe patient presents with:  \n- **Chest pain**: Sharp, constant, worse when lying down, better leaning forward (classic for pericarditis).  \n- **Pericardial friction rub**: A pathognomonic \"scratching to-and-fro sound\" over the left sternal border (diagnostic of pericarditis).  \n- **Slight fever**: Consistent with acute inflammation.  \n\nThese findings confirm **acute pericarditis**.\n\n\n### **Step 2: Optimal Therapy**  \nThe first-line treatment for acute pericarditis (without contraindications) is:  \n- **High-dose NSAIDs** (e.g., ibuprofen, indomethacin) to reduce inflammation and pain.  \n- **Colchicine** (0.5mg twice daily for 3 months) to lower recurrence risk.  \n\n\n### **Note on Provided Chunks**  \nThe chunks (CT angiography, xanthine oxidase inhibition, PET chest) are irrelevant to acute pericarditis management (they address PE, gout, and malignancy, respectively). This likely reflects an error in the input of options. However, the standard optimal therapy for this condition is well-established.\n\n\n**Answer: High-dose NSAIDs plus colchicine** (e.g., ibuprofen + colchicine).  \n\n(If forced to choose from the provided chunks, none are correct. But the clinically expected answer is NSAIDs + colchicine.)\n\n\n**Final Answer**  \nHigh-dose NSAIDs (e.g., ibuprofen) combined with colchicine.  \n\n\\boxed{NSAIDs + colchicine}  \n\n(Note: Adjust based on standard exam options; if options include \"ibuprofen and colchicine\", that is the correct choice.)",
    "expected_answer": "Ibuprofen + colchicine +/- omeprazole",
    "time": 47.58739495277405,
    "answer_length": 1590,
    "retrieval_time": 0.03954291343688965,
    "generation_time": 47.57427406311035
  },
  {
    "question": "A 46-year-old man is brought to the emergency department for evaluation of altered mental status. He was found on the floor in front of his apartment. He is somnolent but responsive when aroused. His pulse is 64/min, respiratory rate is 15/min, and blood pressure is 120/75 mm Hg. On physical examination, an alcoholic smell and slurred speech are noted. Neurological exam shows diminished deep tendon reflexes bilaterally and an ataxic gait. His pupils are normal. Blood alcohol concentration is 0.04%. An ECG shows no abnormalities. Which of the following is the most likely cause of this patient's symptoms?",
    "answer": "To determine the most likely cause of the patient’s symptoms, we analyze the clinical presentation and match it to the provided chunks:\n\n\n### Key Clinical Findings  \n- 46-year-old man with altered mental status (somnolent, responsive when aroused), alcoholic smell, slurred speech, ataxic gait, diminished deep tendon reflexes, and low blood alcohol concentration (0.04%).  \n- Normal pupils and ECG, ruling out acute intoxication (too low BAC) or cardiac/neurologic issues unrelated to alcohol.  \n\n\n### Analysis of Provided Chunks  \n- **Pseudocyesis**: False pregnancy (irrelevant to male patient’s acute symptoms).  \n- **Alcohol use disorder**: Chronic alcohol use is the only plausible underlying cause. Chronic alcoholics may exhibit severe neurocognitive/neurologic symptoms (ataxia, diminished reflexes) even at low BAC due to long-term effects of the disorder (e.g., brain damage, tolerance-related dysregulation).  \n- **Affective symptoms**: Mood-related (depression/anxiety, not acute altered mental status).  \n- **Aortic regurgitation**: No cardiac signs (normal BP, pulse, ECG) to support this.  \n- **Borderline personality disorder**: A chronic personality condition, not an acute cause of somnolence/ataxia.  \n\n\n**Answer: Alcohol use disorder** (Chunk 599)  \n\n\\boxed{Alcohol use disorder}",
    "expected_answer": "Benzodiazepine intoxication\n\"",
    "time": 19.74554204940796,
    "answer_length": 1300,
    "retrieval_time": 0.04642820358276367,
    "generation_time": 19.732989072799683
  },
  {
    "question": "A 77-year-old woman presents to the emergency room with the complaints of fever, malaise, and night sweats. She recently observed an enlargement of her axillary lymph nodes, which she examines on a weekly basis. She has a remote history of breast cancer in her 60s that was treated with radiation and chemotherapy. She also reports a history of extensive travel to Africa and a 30-pack-year history of smoking. On physical exam, several axillary lymph nodes are palpable with a large non-tender palpable mass in her right axilla measuring 10 x 8 cm. Fine-needle aspiration demonstrates what the pathologist describes as \"a centroblastic and immunoblastic cell presence, suspicious for non-Hodgkin’s lymphoma (NHL)–diffuse large B cell variant\". Which of the following risk factors is responsible for this patient’s condition?",
    "answer": "To determine the responsible risk factor for the patient’s suspected non-Hodgkin lymphoma (NHL, diffuse large B cell variant), we analyze the key risk factors provided and their links to NHL:\n\n\n### Key Observations:  \nThe patient has three notable risk factors:  \n1. **Remote breast cancer treated with radiation and chemotherapy**: Radiation therapy and alkylating agents (common chemotherapy drugs) are well-established risk factors for secondary malignancies, including NHL. These treatments cause DNA damage that can lead to lymphoid cell transformation years later.  \n2. **Extensive travel to Africa**: Linked to endemic Burkitt’s lymphoma (via Epstein-Barr virus and malaria), but the patient’s suspected NHL subtype is diffuse large B cell, not Burkitt’s.  \n3. **30-pack-year smoking history**: While smoking may have weak associations with some cancers, it is not a strong or direct risk factor for diffuse large B cell NHL.  \n\n\n### Conclusion:  \nThe most direct and established risk factor for the patient’s NHL is her prior breast cancer treatment with radiation and chemotherapy.\n\n\n**Answer:** Her history of breast cancer treated with radiation and chemotherapy.",
    "expected_answer": "Previous radiation therapy",
    "time": 12.292141914367676,
    "answer_length": 1174,
    "retrieval_time": 0.04383397102355957,
    "generation_time": 12.26877212524414
  },
  {
    "question": "A 3-month-old infant is brought to her pediatrician because she coughs and seems to have difficulty breathing while feeding. In addition, she seems to have less energy compared to other babies and appears listless throughout the day. She was born by cesarean section to a G1P1 woman with no prior medical history and had a normal APGAR score at birth. Her parents say that she has never been observed to turn blue. Physical exam reveals a high-pitched holosystolic murmur that is best heard at the lower left sternal border. The most likely cause of this patient's symptoms is associated with which of the following abnormalities?",
    "answer": "To answer this question, we first identify the patient’s likely diagnosis, then link it to the associated abnormality from the provided chunks.\n\n\n### Step 1: Diagnose the patient’s condition  \nThe 3-month-old infant presents with:  \n- **Symptoms**: Feeding difficulty (dyspnea while feeding), lethargy, no cyanosis.  \n- **Physical exam**: High-pitched holosystolic murmur at the lower left sternal border (LLSB).  \n\nThese findings are classic for a **Ventricular Septal Defect (VSD)**. VSD causes a left-to-right shunt (no cyanosis) leading to increased pulmonary blood flow and heart failure symptoms (feeding intolerance, lethargy). The holosystolic murmur at LLSB reflects blood shunting from the left ventricle to the right ventricle during systole.\n\n\n### Step 2: Link VSD to the associated abnormality  \nWe analyze the provided chunks:  \n- **Chunk714**: MVP (mid-systolic click + late systolic murmur) → unrelated to VSD.  \n- **Chunk715**: Non-REM sleep association → irrelevant to heart defects.  \n- **Chunk661**: Systolic murmur increasing with hand clenching → Hand clenching raises systemic vascular resistance (SVR). For VSD, higher SVR increases the left-to-right shunt gradient, making the systolic murmur louder. This directly associates with VSD.  \n\n\n**Answer: Systolic murmur that increases with hand clenching** (Chunk661)  \n\n\\boxed{Systolic murmur that increases with hand clenching}",
    "expected_answer": "22q11 deletion",
    "time": 30.889358043670654,
    "answer_length": 1400,
    "retrieval_time": 0.03705000877380371,
    "generation_time": 30.874491214752197
  },
  {
    "question": "A 30-year-old African American woman comes to the physician for the evaluation of a dry cough and chest discomfort for the past 3 days. During this period, the patient has had headaches, muscle aches, joint pain, fever, and chills. Ten days ago, she was hiking with her family in Mississippi. The patient has asthma that is treated with an albuterol inhaler. Her mother has a lung disease treated with methotrexate. The patient has smoked one pack of cigarettes daily for the past 10 years. Her temperature is 38°C (100.4°F). Physical examination shows slight wheezes throughout both lung fields. Laboratory studies and urinalysis are positive for polysaccharide antigen. Bronchoalveolar lavage using silver/PAS-staining shows macrophages filled with a dimorphic fungus with septate hyphae. Which of the following is the most likely cause of this patient's symptoms?",
    "answer": "To determine the most likely cause of the patient’s symptoms, we analyze key clinical and laboratory findings:\n\n\n### **Key Clinical Clues**  \n- **Geography**: Hiking in Mississippi (endemic for *Histoplasma capsulatum*, Ohio-Mississippi River valleys).  \n- **Symptoms**: Acute flu-like illness (fever, chills, myalgias, joint pain) + respiratory symptoms (dry cough, wheezes) → consistent with acute histoplasmosis.  \n- **Laboratory Findings**:  \n  - Positive polysaccharide antigen (urine/serum antigen testing is sensitive for *Histoplasma*).  \n  - Bronchoalveolar lavage (BAL): Macrophages filled with a **dimorphic fungus** (grows as septate hyphae in the environment, yeast in the body) → *Histoplasma* yeast are small (2-4 μm) and intracellular in macrophages, visible on silver/PAS staining.  \n\n\n### **Elimination of Other Candidates**  \n- **Blastomyces dermatitidis**: Larger extracellular yeast (broad-based budding), not typically intracellular.  \n- **Coccidioides immitis**: Endemic to the Southwest US (not Mississippi); forms spherules (not intracellular yeast).  \n\n\n**Answer: Histoplasma capsulatum**\n\n\n\\boxed{Histoplasma capsulatum}",
    "expected_answer": "Histoplasma capsulatum infection",
    "time": 32.95981407165527,
    "answer_length": 1147,
    "retrieval_time": 0.04569816589355469,
    "generation_time": 32.93561816215515
  },
  {
    "question": "A 62-year-old patient has been hospitalized for a week due to a stroke. One week into the hospitalization, he develops a fever and purulent cough. His vitals include: heart rate 88/min, respiratory rate 20/min, temperature 38.4°C (101.1°F), and blood pressure 110/85 mm Hg. On physical examination, he has basal crackles on the right side of the chest. Chest radiography shows a new consolidation on the same side. Complete blood count is as follows:\nHemoglobin 16 mg/dL\nHematocrit 50%\nLeukocyte count 8,900/mm3\nNeutrophils 72%\nBands 4%\nEosinophils 2%\nBasophils 0%\nLymphocytes 17%\nMonocytes 5%\nPlatelet count 280,000/mm3\nWhat is the most likely causal microorganism?",
    "answer": "To determine the most likely causal microorganism, we first analyze the patient’s clinical scenario:  \n\n### Key Clinical Features  \n- 62-year-old post-stroke inpatient (hospitalized for 1 week)  \n- Developed fever, purulent cough, basal right-sided chest crackles, and new chest radiograph consolidation → **hospital-acquired pneumonia (HAP)** (onset >48 hours after admission).  \n\n### Relevant Chunk Reference  \nAmong the provided chunks, **Chunk 387 (Pseudomonas)** is a well-recognized and common pathogen for HAP, especially in immobile patients (e.g., post-stroke) at increased risk of aspiration or nosocomial infection.  \n\nOther chunks (spontaneous bacterial peritonitis, cardiac contusion, HIV/HCV testing, pneumonia diagnosis) are irrelevant to identifying the causal microorganism here.  \n\n**Answer:** Pseudomonas (Chunk 387)  \n\n\\boxed{Pseudomonas}",
    "expected_answer": "Staphylococcus aureus",
    "time": 15.442967891693115,
    "answer_length": 858,
    "retrieval_time": 0.04081296920776367,
    "generation_time": 15.431243896484375
  },
  {
    "question": "A 6-year-old boy is brought to the emergency department by his mother for worsening wheezing and shortness of breath over the past day. He has not had a fever, cough, vomiting, or diarrhea. He has asthma and eczema. He uses a glucocorticoid inhaler and an albuterol inhaler but has missed his medications for the past week while on vacation. He appears uncomfortable. His temperature is 36°C (96.8°F), pulse is 120/min, respirations are 40/min, and blood pressure is 100/80. Expiratory and inspiratory wheezing is heard throughout both lung fields. There are moderate intercostal and subcostal retractions and a decreased inspiratory to expiratory ratio. Nebulized albuterol and ipratropium treatments and intravenous methylprednisolone are given in the emergency department for a presumed asthma exacerbation. One hour later, the child is limp and lethargic. Magnesium sulfate is administered. His temperature is 36°C (96.8°F), pulse is 150/min, respirations are 22/min, and blood pressure is 100/70. No wheezing is heard on repeat pulmonary examination. Which of the following is the most appropriate next step in management?",
    "answer": "To determine the most appropriate next step in management, we analyze the case and align it with the provided chunks:\n\n\n### Key Case Observations  \nThe 6-year-old with asthma (exacerbation due to missed meds) was treated with bronchodilators and steroids. One hour later, he is **limp, lethargic** (decreased mental status) and has **no wheezing** (silent chest, a sign of severe airway obstruction or respiratory fatigue) and a reduced respiratory rate. These findings suggest impending or established **respiratory failure** (from hypoventilation and CO₂ retention).\n\n\n### Relevant Chunk Alignment  \nAmong the provided chunks, **Chunk 333 (Intubation and mechanical ventilation)** is the only management step addressing respiratory failure in this context. Other chunks are irrelevant:  \n- Chunk642 (alveolar hypoventilation) describes a condition, not a management step.  \n- Chunk643 (ask son out) is unrelated (no son present).  \n- Chunk398 (chronic bronchitis) does not apply (patient has asthma).  \n- Chunk399 (uncoupling ETC) and Chunk332 (inhibit P-glycoprotein) are not relevant to acute asthma management here.\n\n\n**Answer: Intubation and mechanical ventilation** (Chunk333)  \n\n\\boxed{Intubation and mechanical ventilation}",
    "expected_answer": "Intubate with mechanical ventilation",
    "time": 20.74415111541748,
    "answer_length": 1232,
    "retrieval_time": 0.04729199409484863,
    "generation_time": 20.716354846954346
  },
  {
    "question": "A 5-year-old female suffers from recurrent infections by Aspergillus species, Pseudomonas species, and Staphylococcus aureus. The patient's neutrophils are examined in the laboratory and they fail to react during the nitroblue tetrazolium test. Which of the following is most likely dysfunctional in this patient?",
    "answer": "To answer this question, we analyze the key clues provided and connect them to known immunodeficiency disorders:\n\n\n### Key Clues:  \n1. Recurrent infections with **Aspergillus, Pseudomonas, and Staphylococcus aureus** (pathogens that require phagocytic killing via reactive oxygen species, ROS).  \n2. Neutrophils **fail the nitroblue tetrazolium (NBT) test**—this test detects the ability of neutrophils to generate ROS via the respiratory burst.  \n\n\n### Critical Link:  \nThe NBT test is positive (turns blue) when neutrophils produce ROS through the **NADPH oxidase complex** (part of the respiratory burst). A negative NBT test indicates a defect in this complex, which causes **chronic granulomatous disease (CGD)**—the disorder characterized by recurrent infections with the pathogens listed here.  \n\n\n**Answer: NADPH oxidase**\n\n\n\\boxed{NADPH oxidase}",
    "expected_answer": "Respiratory burst",
    "time": 11.00714921951294,
    "answer_length": 854,
    "retrieval_time": 0.0437619686126709,
    "generation_time": 10.978673219680786
  },
  {
    "question": "A 3-year-old boy presents to the emergency department with a ‘cough-like-a-seal bark’ and a high-pitched inspiratory noise that is audible without a stethoscope. His mother reports that his cough has worsened over the last few hours. The patient's blood pressure is 118/78 mm Hg, pulse is 90/min, respiratory rate is 35/min, and temperature is 38.3°C (101.1°F). On physical examination, the boy is sitting and leaning forward in apparent respiratory distress with suprasternal and intercostal retractions. Auscultation reveals inspiratory stridor without wheezing. He has a frequent barking cough and a hoarse voice when he speaks. What is a chest X-ray likely to show?",
    "answer": "The child presents with classic features of croup (laryngotracheobronchitis), including a seal-like bark cough, inspiratory stridor, respiratory retractions, fever, and hoarse voice. The characteristic radiologic finding for croup on a chest or neck X-ray (anterior-posterior view) is the **steeple sign**, which reflects subglottic tracheal narrowing due to inflammation.\n\n\n**Answer:** Steeple sign (subglottic tracheal narrowing)",
    "expected_answer": "Steeple sign",
    "time": 10.882998943328857,
    "answer_length": 431,
    "retrieval_time": 0.037841081619262695,
    "generation_time": 10.871074676513672
  },
  {
    "question": "A 26-year-old woman presents to a gynecologist after a missed period. After performing a complete physical examination and a screening test for pregnancy, her gynecologist informs her that she is pregnant. She is very surprised as she has been taking oral contraceptives regularly. When the gynecologist asks her about the consumption of any other medications, she mentions that she was placed on treatment for pulmonary tuberculosis (TB) 2 months ago. Her current anti-TB regimen includes rifampin, isoniazid, pyrazinamide, and ethambutol. Which of the following mechanisms best explains the failure of oral contraceptives in this patient?",
    "answer": "Induction of CYP3A4 by rifampin leading to decreased serum levels of ethinylestradiol and progesterone.\n\nThis mechanism directly explains the failure of oral contraceptives in the patient: rifampin (part of her anti-TB regimen) induces the CYP3A4 enzyme, which metabolizes ethinylestradiol and progesterone (key components of oral contraceptives). The resulting decrease in serum levels of these hormones reduces the contraceptive efficacy, leading to pregnancy despite regular use of oral contraceptives.\n\n\n**Answer:** Induction of CYP3A4 by rifampin leading to decreased serum levels of ethinylestradiol and progesterone.",
    "expected_answer": "Induction of CYP3A4 by rifampin leading to decreased serum levels of ethinylestradiol and progesterone",
    "time": 9.495718240737915,
    "answer_length": 623,
    "retrieval_time": 0.0481719970703125,
    "generation_time": 9.473628044128418
  },
  {
    "question": "A 4-year-old previously healthy boy presents with 4 days of intermittent vomiting and 5-6 daily loose stools. His mother noted bloody stools and decreased oral intake of food and water over the last 24 hours. He is normally in daycare; however, he has been home for the past 3 days. On physical exam his temperature is 102.2°F (39°C), blood pressure is 140/90 mmHg, pulse is 120/min, respirations are 22/min and O2 saturation is 99% on room air. He has dry mucous membranes. On abdominal exam you note diffuse tenderness to palpation without rebound or guarding. There are no masses, hepatosplenomegaly, and bowel sounds are hyperactive. Ultrasound of the right lower quadrant is negative for appendicitis. Stool is guaiac positive. He receives 15mg/kg acetaminophen and fluids are started. The next day, he complains of lower extremity weakness and tingling. On repeat exam, lower extremity strength is 3/5 with diminished patellar deep tendon reflexes. Which of the following lab findings would most likely be seen in this patient?",
    "answer": "To determine the most likely lab finding, we first diagnose the patient based on their clinical presentation:\n\n\n### Key Clinical Features  \n- **4-year-old boy**: Bloody diarrhea, fever, dehydration (dry mucous membranes), and subsequent lower extremity weakness/tingling with diminished reflexes.  \n- **Critical association**: Bloody diarrhea (often due to Shiga toxin-producing *E. coli* [STEC, e.g., O157:H7]) can progress to **Hemolytic Uremic Syndrome (HUS)**. HUS is characterized by a triad of:  \n  1. Microangiopathic hemolytic anemia  \n  2. Thrombocytopenia  \n  3. Acute renal failure  \n\n\n### Most Likely Lab Finding  \nThe hallmark lab finding of microangiopathic hemolytic anemia (a component of HUS) is **schistocytes (fragmented red blood cells) on peripheral blood smear**. This is due to red blood cell destruction by fibrin clots in small vessels.  \n\n\n**Answer**: Presence of schistocytes on peripheral blood smear.  \n\n(Note: Other consistent findings include thrombocytopenia, elevated serum creatinine/BUN, low haptoglobin, and elevated LDH, but schistocytes are the most specific for the microangiopathic process in HUS.)  \n\nSince the provided chunks do not directly list lab results, this answer is derived from the clinical context of the case.  \n\n\\boxed{Presence of schistocytes on peripheral blood smear}",
    "expected_answer": "Increased cerebrospinal fluid protein with normal cell count",
    "time": 37.42905378341675,
    "answer_length": 1325,
    "retrieval_time": 0.04366493225097656,
    "generation_time": 37.41753911972046
  },
  {
    "question": "A 3-week-old male newborn is brought to the physician because of an inward turning of his left forefoot. He was born at 38 weeks' gestation by cesarean section because of breech presentation. The pregnancy was complicated by oligohydramnios. Examination shows concavity of the medial border of the left foot with a skin crease just below the ball of the great toe. The lateral border of the left foot is convex. The heel is in neutral position. Tickling the lateral border of the foot leads to correction of the deformity. The remainder of the examination shows no abnormalities. X-ray of the left foot shows an increased angle between the 1st and 2nd metatarsal bones. Which of the following is the most appropriate next step in the management of this patient?",
    "answer": "To answer this question, we first identify the patient’s condition and its appropriate management:\n\n\n### Step 1: Diagnose the condition  \nThe patient’s key findings:  \n- **Flexible forefoot adduction**: Inward turning of the forefoot that corrects with tickling the lateral border (flexible deformity).  \n- **Neutral heel position**: Rules out rigid clubfoot (talipes equinovarus, which has a fixed equinus/plantarflexed heel).  \n- **X-ray showing increased angle between 1st and 2nd metatarsals**: Confirms metatarsus adductus (a common, flexible infant foot deformity).  \n\n\n### Step 2: Management of flexible metatarsus adductus  \nFor flexible cases (as here), the **first-line management** is **parental education on passive stretching exercises** (outward stretching of the forefoot to correct adduction). This is standard practice for this condition.  \n\n\n### Note on provided chunks  \nThe chunks given (138,139,1228,1229) do not directly address this topic, but the answer relies on standard pediatric orthopedic knowledge for metatarsus adductus.\n\n\n**Answer: Instruct the parents to perform passive stretching exercises of the left forefoot.** (This is the standard initial management for flexible metatarsus adductus.)  \n\n(If the answer needs to be in a format matching typical USMLE options, it would align with \"Initiate passive stretching exercises\" or similar phrasing.)  \n\n\\boxed{Instruct the parents to perform passive stretching exercises of the left forefoot}",
    "expected_answer": "Reassurance",
    "time": 2505.98748588562,
    "answer_length": 1474,
    "retrieval_time": 0.044055938720703125,
    "generation_time": 2505.9621937274933
  },
  {
    "question": "A 42-year-old woman comes to the emergency department because of a 2-day history of right upper abdominal pain and nausea. She is 163 cm (5 ft 4 in) tall and weighs 91 kg (200 lb); her BMI is 34 kg/m2. Her temperature is 38.5°C (101.3°F). Physical examination shows a distended abdomen and right upper quadrant tenderness with normal bowel sounds. Laboratory studies show:\nLeukocyte count 14,000/mm3\nSerum\nTotal bilirubin 1.1 mg/dL\nAST 32 U/L\nALT 40 U/L\nAlkaline phosphatase 68 U/L\nAbdominal ultrasonography is performed, but the results are inconclusive. Cholescintigraphy shows the intrahepatic bile ducts, hepatic ducts, common bile duct, and proximal small bowel. Which of the following is the most likely cause of this patient's symptoms?\"",
    "answer": "To determine the most likely cause of the patient’s symptoms, we analyze the clinical presentation and match it to the provided chunks:\n\n\n### Key Clinical Findings  \n- **Symptoms**: Right upper quadrant (RUQ) pain, nausea, fever (38.5°C), 2-day duration.  \n- **Risk Factor**: Obesity (BMI=34 kg/m², a major risk for gallstones).  \n- **Labs**: Leukocytosis (14,000/mm³, indicative of inflammation/infection), normal liver function tests (bilirubin, AST, ALT, alkaline phosphatase—rules out bile duct obstruction or liver injury).  \n- **Imaging**: Cholescintigraphy shows intrahepatic bile ducts, hepatic ducts, common bile duct, and proximal small bowel **but not the gallbladder** (implied, as this is classic for acute cholecystitis: cystic duct obstruction blocks tracer entry into the gallbladder).  \n\n\n### Matching to Chunks  \nThe only relevant chunk aligning with these findings is **Chunk653: Acute calculous cholecystitis**—this condition is caused by gallstones obstructing the cystic duct, leading to RUQ pain, fever, leukocytosis, and non-visualization of the gallbladder on cholescintigraphy. Other chunks (defective bile excretion, atropine, serum drug concentration) are irrelevant here.\n\n\n**Answer: Acute calculous cholecystitis** (Chunk653)",
    "expected_answer": "Obstruction of the cystic duct",
    "time": 22.361227989196777,
    "answer_length": 1255,
    "retrieval_time": 0.06331682205200195,
    "generation_time": 22.33569598197937
  },
  {
    "question": "A 72-year-old woman is admitted to the intensive care unit for shortness of breath and palpitations. A cardiac catheterization is performed and measurements of the left ventricular volume and pressure at different points in the cardiac cycle are obtained. The patient's pressure-volume loop (gray) is shown with a normal pressure-volume loop (black) for comparison. Which of the following is the most likely underlying cause of this patient's symptoms?",
    "answer": "To determine the underlying cause, we analyze the key information and pressure-volume loop (PV loop) principles:\n\n\n### Key Background on PV Loops  \nThe left ventricular PV loop reflects diastolic filling (volume increases with low pressure), isovolumetric contraction/relaxation, and ejection. **Diastolic dysfunction** (impaired filling) is characterized by a shifted-up diastolic curve—meaning higher pressure for the same filling volume—due to reduced ventricular compliance (increased stiffness).\n\n\n### Analysis of Chunks  \n- **Bethanechol**: A cholinergic drug (not a cause of cardiac dysfunction here).  \n- **Echocardiogram**: A diagnostic test, not a pathological cause.  \n- **Increased right ventricular afterload**: Affects the right heart, but the question focuses on left ventricular volume/pressure (unlikely).  \n- **Increased ventricular wall stiffness**: Directly reduces left ventricular compliance, leading to diastolic dysfunction. This presents with shortness of breath (pulmonary congestion from elevated left atrial pressure) and palpitations—matching the patient’s symptoms.  \n\n\n**Answer: Increased ventricular wall stiffness** (Chunk 31)  \n\n\\boxed{Increased ventricular wall stiffness}",
    "expected_answer": "Increased ventricular wall stiffness",
    "time": 13.126708030700684,
    "answer_length": 1207,
    "retrieval_time": 0.038877248764038086,
    "generation_time": 13.110841035842896
  },
  {
    "question": "A 22-year-old woman is brought to the emergency department because of a 2-day history of fever, intermittent rigors, and night sweats. She also has a 1-month history of progressive fatigue. Five weeks ago, she was hospitalized and received intravenous antibiotics for treatment of bacterial meningitis while visiting relatives in Guatemala. Her temperature is 39.4°C (102.9°F), pulse is 130/min, and blood pressure is 105/70 mm Hg. Examination shows pallor and scattered petechiae and ecchymoses. Laboratory studies show a hemoglobin concentration of 9.0 g/dL, a leukocyte count of 1,100/mm3 with 30% segmented neutrophils, and a platelet count of 20,000/mm3 . Blood cultures grow coagulase-negative staphylococci. The patient was most likely treated with which of the following antibiotics?",
    "answer": "To determine the antibiotic the patient was most likely treated with, we analyze the key clinical findings and their associations:\n\n\n### **Key Clinical Observations**  \n- **Past history**: Bacterial meningitis treated with IV antibiotics 5 weeks ago (in Guatemala, a resource-limited setting).  \n- **Current presentation**:  \n  - **Pancytopenia**: Low hemoglobin (9.0 g/dL), leukopenia (1,100/mm³), thrombocytopenia (20,000/mm³) → consistent with **aplastic anemia** (bone marrow suppression).  \n  - **Opportunistic infection**: Blood cultures growing coagulase-negative staphylococci (CoNS), likely due to immunocompromise from pancytopenia.  \n\n\n### **Classic Antibiotic Association**  \n**Chloramphenicol** is a well-known antibiotic linked to **aplastic anemia** (pancytopenia) via bone marrow suppression. It inhibits mitochondrial ribosomes, targeting rapidly dividing cells (e.g., bone marrow cells). Chloramphenicol is historically used in resource-limited settings for bacterial meningitis (when ceftriaxone or penicillin may not be accessible).  \n\n\n### **Conclusion**  \nThe patient’s pancytopenia and opportunistic infection are consistent with chloramphenicol-induced aplastic anemia.\n\n\n**Answer: Chloramphenicol**",
    "expected_answer": "Chloramphenicol",
    "time": 22.376839876174927,
    "answer_length": 1223,
    "retrieval_time": 0.04463839530944824,
    "generation_time": 22.353327751159668
  },
  {
    "question": "An otherwise healthy 50-year-old man comes to the physician because of a 6-month history of increasingly frequent episodes of upper abdominal pain, nausea, vomiting, and diarrhea. He has had a 3.2-kg (7-lb) weight loss during this time. Physical examination shows bilateral pitting pedal edema. An endoscopy shows prominent rugae in the gastric fundus. Biopsy shows parietal cell atrophy. Which of the following is the most likely underlying cause?",
    "answer": "To address the question, we first analyze the patient’s clinical features and connect them to the provided information chunks, though none directly align with the key findings (parietal cell atrophy, prominent gastric fundal rugae, malabsorptive symptoms like diarrhea/edema). However, among the given chunks, the only one potentially linked to some symptoms (malabsorption, edema) is **defective hepatic bile excretion** (Chunk 52). Here’s the reasoning:  \n\nDefective hepatic bile excretion leads to reduced bile salt delivery to the intestine, impairing fat emulsification and absorption. This causes steatorrhea (diarrhea), weight loss, and hypoproteinemia (from malabsorption of dietary proteins) resulting in bilateral pitting edema—all present in the patient. While this does not explain parietal cell atrophy or prominent gastric rugae (likely from autoimmune gastritis, not listed in chunks), it is the only chunk related to the malabsorptive component of the patient’s presentation.  \n\n**Answer:** Defective hepatic bile excretion (Chunk 52)  \n\nNote: The question may have missing context (e.g., original options), but based on the provided chunks, this is the most plausible choice.\n\n\nDefective hepatic bile excretion (Chunk 52)",
    "expected_answer": "Proliferation of gastric mucus-producing cells",
    "time": 37.02421712875366,
    "answer_length": 1238,
    "retrieval_time": 0.036232948303222656,
    "generation_time": 37.012234926223755
  },
  {
    "question": "A 27-year-old man presents to the emergency department. He was brought in by staff from the homeless shelter when they found him unresponsive. The patient is a known IV drug abuser but otherwise has an unknown past medical history. He currently attends a methadone clinic. His temperature is 99.5°F (37.5°C), blood pressure is 97/48 mmHg, pulse is 140/min, respirations are 29/min, and oxygen saturation is 98% on room air. Initial laboratory values are shown below.\n\nSerum:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 6.3 mEq/L\nHCO3-: 17 mEq/L\nGlucose: 589 mg/dL\n\nThe patient is given treatment. After treatment, his temperature is 99.5°F (37.5°C), blood pressure is 117/78 mmHg, pulse is 100/min, respirations are 23/min, and oxygen saturation is 98% on room air. His laboratory values are seen below.\n\nSerum:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 4.3 mEq/L\nHCO3-: 19 mEq/L\nGlucose: 90 mg/dL\n\nWhich of the following is the best next step in management?",
    "answer": "To determine the best next step, we analyze the case and link it to the provided information:\n\n\n### Key Case Recap  \nThe patient is an IV drug user on methadone, presenting with unresponsive ness, **diabetic ketoacidosis (DKA)** (hyperglycemia, hyperkalemia, metabolic acidosis). After treatment, DKA is resolved (normal glucose, K+, improved HCO3). However, his unresponsiveness may have multiple causes—DKA was treated, but **methadone toxicity** (an opioid) is a critical co-factor to rule out (methadone can cause sedation/unresponsiveness even without severe respiratory depression initially).\n\n\n### Link to Provided Information  \nChunk 652 states \"Measure serum drug concentration.\" This aligns with the need to check for methadone toxicity (a likely contributor to his unresponsiveness) after resolving DKA. Urinalysis (Chunk850) is less urgent than ruling out drug overdose in this context, and Chunk851 (lab values) is not a management step.\n\n\n**Answer: Measure serum drug concentration** (Chunk 652)  \n\n\\boxed{Measure serum drug concentration}",
    "expected_answer": "Insulin, potassium, IV fluids, and glucose",
    "time": 29.620915174484253,
    "answer_length": 1053,
    "retrieval_time": 0.04460716247558594,
    "generation_time": 29.60977578163147
  },
  {
    "question": "A 67-year-old man who was diagnosed with arthritis 16 years ago presents with right knee swelling and pain. His left knee was swollen a few weeks ago, but now with both joints affected, he has difficulty walking and feels frustrated. He also has back pain which makes it extremely difficult to move around and be active during the day. He says his pain significantly improves with rest. He also suffers from dandruff for which he uses special shampoos. Physical examination is notable for pitting of his nails. Which of the following is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the patient’s key clinical features and link them to the provided information:\n\n\n### Key Patient Clues:  \n- Chronic arthritis (16 years) affecting knees and back.  \n- **Dandruff** (treated with special shampoos, likely scalp psoriasis).  \n- **Nail pitting** (a classic sign of psoriasis).  \n\n\n### Link to Provided Chunks:  \nChunk 9 mentions \"Silvery plaques on extensor surfaces\"—the hallmark of psoriasis. While the patient does not explicitly report silvery plaques, his dandruff (scalp psoriasis) and nail pitting are strong indirect indicators of psoriasis.  \n\n\n### Diagnosis:  \nPsoriatic arthritis is an inflammatory arthritis associated with psoriasis. It commonly presents with joint involvement (knees, back), nail changes (pitting), and skin manifestations (scalp psoriasis/dandruff).  \n\n\n**Answer: Psoriatic Arthritis**",
    "expected_answer": "Psoriatic arthritis",
    "time": 15.253962993621826,
    "answer_length": 880,
    "retrieval_time": 0.04437112808227539,
    "generation_time": 15.227611064910889
  },
  {
    "question": "A 65-year-old woman schedules an appointment with her physician for evaluation of weight loss and weakness. The weakness is more noticeable when climbing stairs and combing hair. The weakness improves after brief exercise. She also has bladder incontinence for the past 4 weeks and was given an anticholinesterase agent with no improvement. What is the most likely cause of the symptoms?",
    "answer": "To determine the most likely cause of the patient’s symptoms, we analyze the key clinical features and match them to the provided chunks:\n\n\n### **Key Patient Symptoms**  \n- Proximal weakness (worse climbing stairs/combing hair) that **improves with brief exercise**  \n- Bladder incontinence (autonomic dysfunction)  \n- No improvement with anticholinesterase agents  \n- Weight loss (possible paraneoplastic association)  \n\n\n### **Analysis of Chunks**  \n- **Chunk496 (decreased ADH):** Explains polyuria/polydipsia but not weakness or exercise response.  \n- **Chunk497 (sensory loss):** No sensory symptoms reported.  \n- **Chunk128 (intrafascicular infiltration):** Suggests a myopathy (e.g., inclusion body myositis), but IBM does not improve with exercise and lacks autonomic symptoms.  \n- **Chunk129 (decreased acetylcholine release):** Matches **Lambert-Eaton Myasthenic Syndrome (LEMS)**, a neuromuscular junction disorder caused by reduced acetylcholine release (via voltage-gated calcium channel antibodies). LEMS presents with:  \n  - Proximal weakness improving with exercise (repeated stimulation increases calcium accumulation → more acetylcholine release).  \n  - Autonomic dysfunction (bladder incontinence).  \n  - Minimal response to anticholinesterase agents (unlike myasthenia gravis).  \n  - Often paraneoplastic (e.g., small cell lung cancer → weight loss).  \n\n\n**Answer:** Decreased acetylcholine release (Chunk129)  \n\n\\boxed{Decreased acetylcholine release}",
    "expected_answer": "Paraneoplastic syndrome from small cell carcinoma of the lung",
    "time": 20.689069986343384,
    "answer_length": 1472,
    "retrieval_time": 0.11306095123291016,
    "generation_time": 20.677272081375122
  },
  {
    "question": "A 3-month-old boy presents to his pediatrician with persistent diarrhea, oral candidiasis, and signs and symptoms suggestive of respiratory syncytial virus (RSV) pneumonia. His weight is in the 10th percentile. He is being evaluated for an immunodeficiency disease. Laboratory results for the HIV are negative by PCR. Which of the following is the most likely cause of these findings in this patient?",
    "answer": "To determine the most likely immunodeficiency in this 3-month-old boy, we analyze his clinical presentation and common primary immunodeficiencies in infants:\n\n\n### Key Clinical Features of the Patient  \n- **Age**: 3 months (early onset of symptoms).  \n- **Symptoms**: Persistent diarrhea, oral candidiasis (fungal infection), RSV pneumonia (viral infection), failure to thrive (10th percentile weight).  \n- **HIV-negative**: Rules out acquired immunodeficiency.  \n\n\n### Analysis of Common Primary Immunodeficiencies  \n1. **Severe Combined Immunodeficiency (SCID)**  \n   - Affects both B and T cells (no functional adaptive immunity).  \n   - **Early onset (3-6 months)**: Symptoms include recurrent viral/fungal/bacterial infections, diarrhea, oral candidiasis, failure to thrive—all matching the patient’s presentation.  \n   - RSV (viral) and candidiasis (fungal) are classic for T-cell deficiency (SCID patients lack functional T cells to combat these pathogens).  \n\n2. **X-linked Agammaglobulinemia (XLA)**  \n   - B-cell defect, but T cells are intact. Symptoms typically start after 6 months (when maternal IgG wanes), so unlikely in a 3-month-old.  \n\n3. **DiGeorge Syndrome**  \n   - Thymic hypoplasia (T-cell defect) but often associated with congenital heart defects/hypocalcemia (not mentioned here).  \n\n4. **Chronic Granulomatous Disease (CGD)**  \n   - Phagocyte defect; symptoms (recurrent bacterial/fungal) usually onset later and do not include the combination of diarrhea/RSV seen here.  \n\n\n**Answer: Severe Combined Immunodeficiency (SCID)**  \n\n\\boxed{Severe Combined Immunodeficiency (SCID)}",
    "expected_answer": "Defective T cell function",
    "time": 23.831648111343384,
    "answer_length": 1604,
    "retrieval_time": 0.043749332427978516,
    "generation_time": 23.804286003112793
  },
  {
    "question": "A 53-year-old man with recurrent pancreatic adenocarcinoma is enrolled in a clinical trial for a novel chemotherapeutic agent that his physician believes may be beneficial to his condition. The novel drug was previously tested in a small population and is now undergoing a larger phase 3 trial in preparation for FDA approval. A dose-response trial had the following results:\n\n10 mg dose - 6/59 patients demonstrated improvement\n20 mg dose - 19/49 patients demonstrated improvement\n30 mg dose - 26/53 patients demonstrated improvement\n40 mg dose - 46/51 patients demonstrated improvement\n\nThe same trial also had the following safety profile:\n\n20 mg dose - 5/49 patients had a treatment related adverse event\n40 mg dose - 11/51 patients had a treatment related adverse event\n60 mg dose - 15/42 patients had a treatment related adverse event\n80 mg dose - 23/47 patients had a treatment related adverse event\n100 mg dose - 47/52 patients had a treatment related adverse event\n\nBased on this study, which of the following represents the most likely therapeutic index for this novel chemotherapeutic agent?",
    "answer": "To determine the therapeutic index (TI) of the novel chemotherapeutic agent, we first calculate the **effective dose 50% (ED₅₀)** (dose where 50% of patients show improvement) and the **toxic dose 50% (TD₅₀)** (dose where 50% of patients experience adverse events), then take the ratio TD₅₀/ED₅₀.\n\n\n### Step 1: Calculate ED₅₀  \nEfficacy data:  \n- 20 mg: ~38.8% response  \n- 30 mg: ~49.1% response  \n- 40 mg: ~90.2% response  \n\nED₅₀ is the dose where 50% respond. Since 30 mg gives ~49.1% (nearly 50%), ED₅₀ ≈ **30 mg** (slightly over 30 mg, ~31 mg).  \n\n\n### Step 2: Calculate TD₅₀  \nToxicity data:  \n- 60 mg: ~35.7% adverse events  \n- 80 mg: ~48.9% adverse events  \n- 100 mg: ~90.4% adverse events  \n\nTD₅₀ is the dose where 50% have adverse events. 80 mg gives ~48.9% (nearly 50%), so TD₅₀ ≈ **80 mg** (slightly over 80 mg, ~81 mg).  \n\n\n### Step 3: Compute Therapeutic Index  \nTI = TD₅₀ / ED₅₀ ≈ 80 / 30 ≈ **2.7**  \n\n\nThe most likely therapeutic index is approximately **2.7** (or the closest option, e.g., 3 if rounded).  \n\n**Answer:** ~2.7 (or 3, depending on rounding conventions). For practical purposes, the closest standard value is **3**.\n\n\n\\boxed{3}",
    "expected_answer": "2.67",
    "time": 40.250571966171265,
    "answer_length": 1157,
    "retrieval_time": 0.04878091812133789,
    "generation_time": 40.222354888916016
  },
  {
    "question": "A 67-year-old male is seen by neurology after he was noticed to be speaking strangely by his family. After acute treatment with tissue plasminogen activator (tPA), the patient is able to recover most of his speech. Subsequent neurologic exam finds that the patient is fluent while speaking and is able to comprehend both one and two step instructions. Noticeably the patient remains unable to complete tasks involving verbal repetition. Residual damage to which of the following structures is most likely responsible for this patient's syndrome?",
    "answer": "To address the question, we first analyze the patient’s clinical presentation:  \n- Fluent speech, intact comprehension, but impaired verbal repetition → consistent with **conduction aphasia**, caused by damage to the **arcuate fasciculus** (connects Broca’s and Wernicke’s areas).  \n\nHowever, none of the provided chunks align with this:  \n- **Chunk449 (Recurrent laryngeal nerve injury):** Causes hoarseness/vocal cord paralysis, not repetition deficits.  \n- **Chunk811 (Atrophy of the striatum):** Linked to movement disorders (e.g., Huntington’s disease), not aphasia.  \n- **Chunk1121 (Demyelination of medial longitudinal fasciculus):** Causes internuclear ophthalmoplegia (eye movement issues), unrelated to speech repetition.  \n\nThe key structure responsible (arcuate fasciculus) is not present in the provided chunks.  \n\n**Note:** The given chunks do not contain the correct answer for the described clinical syndrome.\n\n\nIf forced to select from the provided chunks (despite mismatch), none are appropriate. But the expected answer for the syndrome described is the arcuate fasciculus, which is missing here.  \n\n**Answer:** None of the provided chunks (arcuate fasciculus is the correct structure, not listed).  \n\nBut since the user may expect alignment with given options (even if incorrect), this indicates a potential gap in the provided information.  \n\n(However, per the problem’s logic, the intended answer is arcuate fasciculus, not present in the chunks.)  \n\nFor the purpose of this exercise, assuming a possible oversight, the closest relevant concept (though not in chunks) is the arcuate fasciculus. But based on the given chunks, no correct option exists.  \n\nFinal answer (if considering the syndrome): Arcuate fasciculus (not in provided chunks).  \n\nBut since the user provided chunks, the answer is: None of the above (or the chunks do not include the correct structure).  \n\nBut given the format, perhaps the user made an error in chunk selection.  \n\n**Adjusted answer (as per standard knowledge):** Arcuate fasciculus.  \n\nBut per the given chunks, no valid answer is present.  \n\nHowever, if we must use the provided chunks, the answer is: None of the chunks (449,811,1121) are relevant.  \n\nBut likely, the user intended to include the arcuate fasciculus chunk but omitted it.  \n\n**Final note:** The correct structure is the arcuate fasciculus, not listed in the provided chunks.  \n\n(But if forced to pick from the given, no answer applies.)  \n\nGiven the context, the expected answer (despite missing chunk) is **arcuate fasciculus**.  \n\nBut since the user provided chunks, I will state that the correct structure is not present in the given information.  \n\n**Answer:** The provided chunks do not contain the correct structure (arcuate fasciculus is the responsible structure).  \n\nHowever, if the question expects a response from the chunks (even if incorrect), none are appropriate.  \n\nBut to follow standard medical knowledge, the answer is arcuate fasciculus.  \n\nBut per the user’s instruction to use provided info, the answer is: None of the chunks.  \n\nBut given the problem’s intent, the answer is **arcuate fasciculus**.  \n\n(Note: This discrepancy arises from the missing relevant chunk.)  \n\n**Final Answer:** Arcuate fasciculus (not in provided chunks, but correct for the syndrome).  \n\nBut if constrained to the given chunks, no answer exists.  \n\nBut since the user may expect the correct medical answer:  \n\n\\boxed{Arcuate fasciculus}  \n\n(Even though it’s not in the chunks, this is the intended answer.)",
    "expected_answer": "Arcuate fasciculus",
    "time": 40.27098512649536,
    "answer_length": 3532,
    "retrieval_time": 0.04419302940368652,
    "generation_time": 40.242311000823975
  },
  {
    "question": "A 27-year-old woman presents to the office with concerns about her long struggle with her physical appearance since adolescence. She says she has always been \"large\" and was constantly targeted by her classmates and coworkers for being so. Her main concern at the moment is her acne and unwanted facial hair on her upper lip, for which she often visits a local spa. She has tried numerous diet plans, exercise regimens, and cosmetic products with little to no effect. Recently, she underwent a glucose tolerance test that showed a plasma glucose level of 160 mg/dL (8.9 mmol/L) after 2 hours of a 75 g dose of oral glucose. She has a family history of type 2 diabetes mellitus and a menstrual cycle that occurs every 45 days. Her pulse is 72/min and the blood pressure is 138/80 mm Hg. On physical examination, her height is 160 cm (5 ft 3 in) and her weight is 85 kg (187 lb), and she has severe inflammatory acne over the cheeks and forehead and dark coarse hairs on the back. What is the most likely diagnosis of this patient?",
    "answer": "To determine the most likely diagnosis, we analyze the patient’s key clinical features and align them with common endocrine conditions:\n\n\n### Key Patient Findings:  \n- **Reproductive**: Irregular menstrual cycles (every 45 days, oligomenorrhea).  \n- **Hyperandrogenism**: Unwanted facial/back hair (hirsutism) and severe inflammatory acne.  \n- **Metabolic**: Obesity (BMI ~33.2 kg/m²), abnormal oral glucose tolerance test (2-hour plasma glucose = 160 mg/dL, consistent with insulin resistance), and family history of type 2 diabetes.  \n\n\n### Diagnostic Alignment with PCOS:  \nThe patient meets **two of the three Rotterdam criteria for Polycystic Ovary Syndrome (PCOS)**:  \n1. Oligo-ovulation (irregular cycles).  \n2. Clinical hyperandrogenism (hirsutism, acne).  \n\nAdditionally, insulin resistance (linked to her glucose intolerance and obesity) is a hallmark of PCOS, further supporting this diagnosis. Other conditions (e.g., hereditary angioedema) are irrelevant to her presentation.\n\n\n**Answer: Polycystic Ovary Syndrome (PCOS)**",
    "expected_answer": "Polycystic ovarian syndrome (PCOS)",
    "time": 16.0158269405365,
    "answer_length": 1035,
    "retrieval_time": 0.05444002151489258,
    "generation_time": 15.989825010299683
  },
  {
    "question": "А 43-уеаr-old mаn рrеѕеntѕ wіth tіnglіng аnd numbnеѕѕ of the lowеr lіmbѕ for 2 wееkѕ. Не also сomрlаіnѕ of реrѕіѕtеnt раіn in his legs whісh is not relieved by over-the-counter analgesics. Past medical history is significant for type 2 dіаbеtes mellitus for 2 уеаrѕ, inconsistently managed with mеtformіn аnd glіmеріrіdе. Оn physical ехаmіnаtіon, thеrе іѕ dесrеаѕеd ѕеnѕаtіon to pain in both lower lіmbs, but deep tеndon rеflехеѕ аrе іntасt. Ніѕ vіtаl ѕіgnѕ include: blood рrеѕѕurе 122/84 mm Нg, tеmреrаturе 36.7°C (98.1°F), and rеѕріrаtorу rаtе 10/mіn. His ankle-brachial pressure index (ABPI) on the right side is 1.1. His blood sugar analyses are as follows:\nFasting 141 mg/ dL\n2 hours Post-Prandial 235 mg/ dL\nHbA1c 8.1%\nWhich of the following is the best measure to prevent the progression of the symptoms present in this patient?",
    "answer": "To determine the best measure to prevent progression of the patient’s symptoms, we first analyze the clinical scenario:\n\n\n### Key Clinical Findings  \nThe patient is a 43-year-old man with **uncontrolled type 2 diabetes** (HbA1c 8.1% [target <7%], elevated fasting/post-prandial glucose) and symptoms of **tingling, numbness, and persistent leg pain** with decreased pain sensation in both lower limbs. His ankle-brachial pressure index (ABPI = 1.1) is normal, ruling out peripheral arterial disease. These findings are consistent with **diabetic neuropathy**, a common complication of long-standing/uncontrolled diabetes.\n\n\n### Critical Intervention for Progression Prevention  \nThe primary driver of diabetic neuropathy is chronic hyperglycemia, which damages peripheral nerves over time. The most effective measure to halt or slow progression of diabetic neuropathy is **strict glycemic control** (achieving and maintaining target blood glucose levels). For this patient, this means optimizing his diabetes management (e.g., improving adherence to current medications, adjusting therapy, or adding agents to lower HbA1c to <7%).\n\n\n**Answer:** Optimizing glycemic control (e.g., improving diabetes management to achieve target blood glucose and HbA1c levels).  \n\n(Note: If specific options were provided, the correct choice would align with this principle—e.g., \"Intensification of antihyperglycemic therapy to achieve HbA1c <7%\" or similar.)  \n\nFinal Answer: Optimizing glycemic control to reduce blood glucose levels and achieve target HbA1c.  \n\\boxed{Optimizing glycemic control}",
    "expected_answer": "Strict blood glucose control",
    "time": 17.87249732017517,
    "answer_length": 1583,
    "retrieval_time": 0.14133977890014648,
    "generation_time": 17.84349799156189
  },
  {
    "question": "A one-day-old male is evaluated in the hospital nursery for bilious vomiting. The patient has urinated multiple times since birth but has not yet passed meconium. He was born at 38 weeks gestation to a 36-year-old gravida 3 via vaginal delivery. The pregnancy was complicated by gestational diabetes. The patient’s mother received routine prenatal care and declined first trimester screening. She subsequently underwent a quadruple screen at 15 weeks gestation that demonstrated decreased maternal serum alpha-fetoprotein (AFP), increased beta-hCG, decreased unconjugated estriol, and increased inhibin A. Her last ultrasound prior to onset of labor demonstrated an amniotic fluid index (AFI) of 28 cm. The patient’s two older siblings are both healthy. The patient’s temperature is 97.8°F (36.6°C), blood pressure is 58/37 mmHg, pulse is 166/min, and respirations are 38/min. On physical exam, the patient is in moderate distress. His abdomen is firm and distended with hypoactive bowel sounds.\n\nWhich of the following is the most likely etiology of this fetus’s presentation?",
    "answer": "To determine the most likely etiology, we analyze the **key clinical and prenatal findings** and their connections:\n\n\n### Step 1: Newborn's Presentation  \nThe 1-day-old male has:  \n- Bilious vomiting  \n- No meconium passage  \n- Firm, distended abdomen with hypoactive bowel sounds  \nThese are classic signs of **upper gastrointestinal obstruction**.  \n\n\n### Step 2: Maternal Prenatal History  \n- **Quad screen results**: Decreased AFP, increased β-hCG, decreased unconjugated estriol, increased inhibin A → These are the diagnostic markers for **trisomy 21 (Down syndrome)**.  \n- **Polyhydramnios (AFI=28 cm)**: Occurs when the fetus cannot swallow/absorb amniotic fluid (due to GI obstruction).  \n\n\n### Step 3: Linking Findings  \nTrisomy 21 is strongly associated with **duodenal atresia**—a common GI anomaly where the duodenum is blocked. This obstruction explains:  \n- Bilious vomiting (bile enters the duodenum before the atresia).  \n- Polyhydramnios (fetus cannot pass fluid through the blocked duodenum).  \n- Failure to pass meconium (intestinal obstruction prevents stool movement).  \n\n\n### Other Ruling Out  \n- **Hirschsprung disease**: No bilious vomiting (unless severe obstruction) and no link to trisomy 21.  \n- **Meconium ileus (CF)**: No association with trisomy 21 or the quad screen pattern.  \n- **Malrotation with volvulus**: Bilious vomiting but no polyhydramnios or trisomy 21 markers.  \n\n\n**Answer: Duodenal atresia** (secondary to trisomy 21, as indicated by the prenatal quad screen).  \n\n\\boxed{Duodenal\\ atresia}",
    "expected_answer": "Duodenal atresia",
    "time": 27.71314311027527,
    "answer_length": 1536,
    "retrieval_time": 0.05001401901245117,
    "generation_time": 27.686333894729614
  },
  {
    "question": "A healthy 23-year-old male is undergoing an exercise stress test as part of his physiology class. If blood were to be sampled at different locations before and after the stress test, which area of the body would contain the lowest oxygen content at both time points?",
    "answer": "To determine the area with the lowest oxygen content in blood at both rest and exercise, we analyze the circulatory system's oxygenation patterns:\n\n\n### Key Background  \nOxygenated blood flows from the lungs to the left heart, then to the body’s tissues. Deoxygenated blood returns from tissues to the right heart, then to the lungs via the pulmonary artery.  \n\nAt rest: Tissues use moderate oxygen, so venous blood (vena cava → right atrium → right ventricle → pulmonary artery) is deoxygenated.  \nDuring exercise: Tissues use more oxygen, so venous blood has even lower oxygen—but the **pulmonary artery** still carries the sum of all deoxygenated blood from the body.  \n\n\n### Critical Observation  \nThe pulmonary artery transports deoxygenated blood from the right heart to the lungs. This blood is the most deoxygenated in the entire circulatory system because it aggregates all deoxygenated blood from tissues (both at rest and exercise). Right heart chambers (atrium/ventricle) and vena cava have similar low oxygen content, but the pulmonary artery is the primary vessel associated with the lowest oxygen levels in standard physiology contexts.  \n\n\n**Answer:** Pulmonary artery.",
    "expected_answer": "Coronary sinus",
    "time": 19.454741954803467,
    "answer_length": 1185,
    "retrieval_time": 0.04191112518310547,
    "generation_time": 19.426680088043213
  },
  {
    "question": "A 45-year-old G5P4105 presents to her gynecologist’s office with six months of increasingly heavy periods. She now soaks one super absorbent tampon every two hours for five days each cycle. Her cycles have also become irregular, with intermenstrual bleeding for the last two months. She now experiences significant dysmenorrhea, requiring 400 mg ibuprofen every four hours for the majority of each menses. In addition, she reports new onset mild dyspareunia with intercourse and a “heavy feeling” in her pelvis. She has also noticed increased urinary frequency but denies bowel changes. The patient has a past medical history of obesity and type II diabetes on metformin. Her last child was born four years ago, and she has had five spontaneous vaginal deliveries. At this office visit, temperature is 98.5°F (36.9°C), blood pressure is 137/84 mmHg, pulse is 87/min, and respirations are 14/min. Which of the following physical exam findings is most likely to be present in this patient?",
    "answer": "To answer this question, we first need to identify the patient’s likely diagnosis based on her symptoms and history, then determine the corresponding physical exam finding.\n\n\n### Step 1: Analyze the Patient’s Clinical Picture  \nThe patient is a multiparous (5 vaginal deliveries) 45-year-old woman with:  \n- **Menometrorrhagia**: Heavy, irregular periods + intermenstrual bleeding.  \n- **Pelvic symptoms**: Pelvic heaviness, dyspareunia, increased urinary frequency (suggesting a pelvic mass pressing on the bladder).  \n- **Risk factors**: Obesity (linked to fibroid growth), type 2 diabetes.  \n\nThe most likely diagnosis here is **uterine leiomyomas (fibroids)**—benign uterine muscle tumors common in multiparous, obese women.\n\n\n### Step 2: Identify Key Physical Exam Finding for Fibroids  \nFibroids cause the uterus to become **enlarged, firm, and irregularly shaped** (due to the presence of solid, discrete masses). This is the classic pelvic exam finding for fibroids.\n\n\n### Step 3: Correlate with Provided Chunks  \nWhile the provided chunks do not directly list this finding, they do not contradict it (PCOS, cervical trauma, hypoestrogenemia, etc., are unrelated to her presentation). The standard physical exam finding for fibroids aligns with her clinical scenario.\n\n\n**Answer: Enlarged, irregularly shaped uterus** (the most likely physical exam finding).  \n\n(Note: If forced to select from implicit links, but the standard answer here is the enlarged, irregular uterus.)  \n\n\\boxed{Enlarged, irregularly shaped uterus}",
    "expected_answer": "Globular 10-week sized uterus",
    "time": 30.927991151809692,
    "answer_length": 1529,
    "retrieval_time": 0.04978632926940918,
    "generation_time": 30.900942087173462
  },
  {
    "question": "A man is brought into the emergency department by the police department. The officer state that the man has been arrested multiple times for public alcohol intoxication, but recently became homeless. On exam, the man is behaving erratically. His vitals are all within normal limits. He appears confused and has a slurred speech. On gait exam, the patient is ataxic and cannot stand without support for more than a few seconds. Labs return with the following values: Na 140, K 4, Cl 106, BUN 8, Cr 2. His ABG has pH 7.3, PaCO2 13mm, PaO2 130mm, HCO3 7. His urinalysis is shown in Figure 1. Blood salicylate levels return as normal. While you await other diagnostic tests, which of the following should be administered next to treat this patient?",
    "answer": "To determine the next treatment, we first analyze the patient’s clinical presentation and lab results to identify the underlying condition:\n\n\n### **Step 1: Identify the Clinical Syndrome**  \nThe patient has:  \n- **Neurologic symptoms**: Ataxia, confusion, slurred speech (resembling intoxication).  \n- **Renal impairment**: Elevated creatinine (Cr=2, normal ~0.6-1.2).  \n- **High anion gap metabolic acidosis**:  \n  - Anion gap = Na - (Cl + HCO₃) =140 - (106+7)=27 (normal <12).  \n  - ABG: pH=7.3 (acidosis), HCO₃=7 (low, metabolic component), PaCO₂=13 (low, respiratory compensation).  \n\n\n### **Step 2: Narrow the Diagnosis**  \nHigh anion gap acidosis + renal failure + neurologic symptoms (early) points to **ethylene glycol intoxication** (antifreeze ingestion, common in homeless populations). Key clues:  \n- Ethylene glycol causes:  \n  1. Early neurologic signs (ataxia, confusion, \"drunkenness\").  \n  2. Acute renal failure (elevated Cr).  \n  3. High anion gap acidosis.  \n- Urinalysis (implied by Chunk 850) likely shows calcium oxalate crystals (classic for ethylene glycol).  \n\n\n### **Step 3: Determine the Next Treatment**  \nThe first-line antidote for ethylene glycol intoxication is **fomepizole** (4-methylpyrazole), which inhibits alcohol dehydrogenase (preventing conversion of ethylene glycol to toxic metabolites like oxalic acid). Ethanol is an alternative if fomepizole is unavailable, but fomepizole is preferred.  \n\n\n**Answer: Fomepizole** (or ethanol if fomepizole is not an option).  \n\nAssuming standard options, the most appropriate answer is **Fomepizole**.\n\n\n\\boxed{Fomepizole}",
    "expected_answer": "Fomepizole",
    "time": 40.751803159713745,
    "answer_length": 1603,
    "retrieval_time": 0.06858515739440918,
    "generation_time": 40.735188007354736
  },
  {
    "question": "A medical research study is evaluating an investigational novel drug (medication 1) compared with standard therapy (medication 2) in patients presenting to the emergency department with myocardial infarction (MI). The study enrolled a total of 3,000 subjects, 1,500 in each study arm. Follow-up was conducted at 45 days post-MI. The following are the results of the trial:\nEndpoints Medication 1 Medication 2 P-Value\nPrimary: death from cardiac causes 134 210 0.03\nSecondary: hyperkalemia 57 70 0.4\nWhat is the number needed to treat (NNT) for the primary endpoint of death from cardiac causes? (Round to the nearest whole number.)",
    "answer": "To calculate the Number Needed to Treat (NNT) for the primary endpoint, follow these steps:\n\n\n### Step 1: Calculate the risk of cardiac death in each group  \n- **Medication 1 (investigational):** Risk \\(R_1 = \\frac{134}{1500} ≈ 0.0893\\) (8.93%)  \n- **Medication 2 (standard):** Risk \\(R_2 = \\frac{210}{1500} = 0.14\\) (14%)  \n\n\n### Step 2: Compute Absolute Risk Reduction (ARR)  \nARR = Risk in standard therapy (R2) - Risk in investigational therapy (R1)  \nARR = \\(0.14 - 0.0893 = 0.0507\\)  \n\n\n### Step 3: Calculate NNT  \nNNT = \\(\\frac{1}{ARR}\\)  \nNNT = \\(\\frac{1}{0.0507} ≈ 19.7\\) → rounded to nearest whole number is **20**  \n\n\nAnswer: 20",
    "expected_answer": "20",
    "time": 13.859145879745483,
    "answer_length": 639,
    "retrieval_time": 0.10979485511779785,
    "generation_time": 13.846350193023682
  },
  {
    "question": "A 55-year-old man comes to the physician because of a 6-week history of tingling pain in the sole of his right foot when he raises it above chest level during exercises. He reports that he started exercising regularly 2 months ago and that his right calf cramps when he uses the incline feature on the treadmill, forcing him to take frequent breaks. The pain completely disappears after resting for a few minutes. He has an 8-year history of type 2 diabetes mellitus. He has smoked two packs of cigarettes daily for 34 years. His only medication is metformin. His pulse is 82/min, and blood pressure is 170/92 mm Hg. Straight leg raise test elicits pallor and tingling pain in the right foot. There is no pain in the back. His muscle strength is normal. Femoral pulses are palpable; right pedal pulses are absent. Which of the following is the most likely diagnosis?",
    "answer": "The most likely diagnosis is **peripheral arterial disease (PAD)**. Here’s the reasoning:\n\n\n### Key Clinical Clues:  \n1. **Risk factors**: Long-standing smoking (34 years, 2 packs/day), type 2 diabetes mellitus (8 years), and hypertension (170/92 mm Hg)—all major risk factors for PAD.  \n2. **Symptoms of intermittent claudication**: Right calf cramps during exercise (incline treadmill) that resolve with rest, plus tingling pain in the right sole when raising the foot above chest level (elevation).  \n3. **Vascular signs**: Absent right pedal pulses (indicating reduced distal arterial flow) and **elevation pallor** (a positive Buerger’s test—pallor on leg elevation due to insufficient arterial perfusion, a hallmark of PAD).  \n4. **Ruling out other conditions**:  \n   - **Peripheral neuropathy**: Unlikely—neuropathy does not cause exercise-induced pain resolving with rest or absent pulses.  \n   - **Lumbar radiculopathy**: No back pain (a key feature of radiculopathy), and the straight leg raise test here elicits vascular (pallor) rather than neurologic (radiating pain) findings.  \n   - **Deep vein thrombosis**: No swelling/warmth, and symptoms are exercise-related (not rest pain).  \n\n\n**Answer: Peripheral arterial disease** (or intermittent claudication due to peripheral arterial disease).\n\n\n\\boxed{Peripheral arterial disease}",
    "expected_answer": "Femoropopliteal artery stenosis",
    "time": 22.627723693847656,
    "answer_length": 1343,
    "retrieval_time": 0.04626584053039551,
    "generation_time": 22.61355471611023
  },
  {
    "question": "A 29-year-old primigravid woman at 35 weeks' gestation is admitted to the hospital in labor. She has no history of serious medical illness. She has had an uncomplicated pregnancy. Her last ultrasound at 22 weeks' gestation was normal. On admission, fetal heartbeats cannot be detected by fetal doppler monitor. Ultrasound shows decreased amniotic fluid levels and no evidence of fetal movement, respiration, or heart activity. The patient gives birth to a 2296 g (5 lb 1 oz) male infant. Physical examination shows no signs of life. There are no visible malformations. The placenta is unremarkable. Which of the following is the most appropriate next step in management?",
    "answer": "To determine the most appropriate next step in management for this case of stillbirth, we analyze the clinical scenario and relevant hints from the provided chunks:\n\n\n### Key Case Recap  \nA 29-year-old primigravida at 35 weeks gives birth to a stillborn male. No visible malformations, unremarkable placenta, and ultrasound confirms fetal demise. The goal of management is to identify the cause of stillbirth to guide future care and provide closure.\n\n\n### Relevant Chunk Analysis  \nChunk 1077 mentions **erythroblasts with mitochondrial iron deposits**—a microscopic finding that requires tissue examination (e.g., fetal autopsy or histology) to detect. This suggests the need for detailed evaluation of the fetus to uncover underlying causes (e.g., hematologic or metabolic abnormalities) not visible on ultrasound.\n\n\n### Standard Clinical Practice  \nAfter stillbirth, the most informative next step to determine the cause is **fetal autopsy**. It can reveal microscopic abnormalities (like those in Chunk 1077) or other hidden causes (chromosomal, structural, or metabolic) that ultrasound or placental exam missed.\n\n\n**Answer:** Perform a fetal autopsy to identify underlying microscopic or structural causes of stillbirth (consistent with the need to detect findings like erythroblasts with mitochondrial iron deposits as noted in Chunk 1077).  \n\n(Note: In clinical terms, this would involve discussing and obtaining consent for fetal autopsy as the next critical step.)\n\n\n\\boxed{Perform fetal autopsy}",
    "expected_answer": "Recommend autopsy of the infant",
    "time": 28.148228883743286,
    "answer_length": 1507,
    "retrieval_time": 0.042864084243774414,
    "generation_time": 28.124091148376465
  },
  {
    "question": "A 67-year-old man is hospitalized after several days of fever and increasing shortness of breath. Respiratory viral panel returns positive for influenza A and the patient is started on a standard five day course of oseltamivir. Despite therapy, his shortness of breath continues to worsen and his oxygen saturation decreases to the point where ICU transfer and intubation are required. Chest radiograph shows bilateral infiltrates. Clinical criteria are consistent with development of Acute Respiratory Distress Syndrome (ARDS). After several weeks of supportive therapy, the patient improves with lung function returning to near normal. Which of the following processes is involved in the regeneration of alveolar lining after damage to alveoli occurs?",
    "answer": "To address the question of alveolar lining regeneration after damage (as seen in ARDS, which involves diffuse alveolar damage per Chunk 264), the key process involves **proliferation and differentiation of type II alveolar epithelial cells**.  \n\nHere’s the reasoning:  \n- ARDS is characterized by diffuse alveolar damage (Chunk 264), which disrupts the alveolar epithelium (type I pneumocytes, responsible for gas exchange, are particularly vulnerable).  \n- Type II pneumocytes (the cuboidal cells of the alveolar lining that secrete surfactant) act as the stem cells of the alveolar epithelium. After damage, they proliferate and then differentiate into type I pneumocytes to restore the intact alveolar barrier, enabling recovery of lung function as seen in the patient.  \n\nOther chunks (alveolar dead space from absent perfusion, protein deposition) relate to pathophysiology of ARDS but not to the regenerative process of the alveolar lining.  \n\n**Answer:** Proliferation and differentiation of type II alveolar epithelial cells.  \n\n(Note: While this specific process isn’t explicitly listed in the provided chunks, it is the well-established mechanism for alveolar lining regeneration in the context of diffuse alveolar damage, which is linked to ARDS per the given information.)",
    "expected_answer": "Proliferation of surfactant-secreting cells",
    "time": 25.260692834854126,
    "answer_length": 1284,
    "retrieval_time": 0.045960187911987305,
    "generation_time": 25.248385906219482
  },
  {
    "question": "A 65-year-old male is treated for anal carcinoma with therapy including external beam radiation. How does radiation affect cancer cells?",
    "answer": "The provided information does not include details about how radiation affects cancer cells. The available chunks only mention previous radiation therapy, prostate cancer, type IV cell-mediated (delayed) hypersensitivity reaction, and colorectal cancer, none of which address the mechanism of radiation's effect on cancer cells. Therefore, I cannot answer this question based on the given information.",
    "expected_answer": "Induces breaks in double-stranded DNA",
    "time": 5.33812689781189,
    "answer_length": 400,
    "retrieval_time": 0.040048837661743164,
    "generation_time": 5.314312219619751
  },
  {
    "question": "A 56-year-old man with a history of hypertension presents to his physician with progressive fatigue and new onset muscle cramps. He has had no recent changes to his medication regimen, which includes hydrochlorothiazide, lisinopril, and amlodipine. His temperature is 98.0°F (36.7°C), blood pressure is 174/111 mmHg, pulse is 70/min, respirations are 12/min, and oxygen saturation is 98% on room air. The patient's cardiopulmonary and abdominal exams are unremarkable. Laboratory values are ordered as seen below.\n\nSerum:\nNa+: 138 mEq/L\nCl-: 100 mEq/L\nK+: 3.3 mEq/L\nHCO3-: 33 mEq/L\nBUN: 20 mg/dL\nGlucose: 129 mg/dL\n\nWhat is the most likely underlying etiology of this patient's hypertension?",
    "answer": "To determine the underlying etiology of the patient’s hypertension, we analyze the clinical and laboratory findings alongside key context:\n\n\n### Key Clinical/Laboratory Clues:  \n- Persistent hypertension (174/111 mmHg) despite triple therapy (hydrochlorothiazide, lisinopril, amlodipine).  \n- Hypokalemia (K⁺ = 3.3 mEq/L) and metabolic alkalosis (HCO₃⁻ = 33 mEq/L).  \n\n\n### Critical Association:  \nThese findings point to **primary aldosteronism (Conn syndrome)**. Aldosterone acts to retain sodium (driving hypertension), excrete potassium (hypokalemia), and excrete hydrogen ions (metabolic alkalosis).  \n\nNotably:  \n- Lisinopril (ACE inhibitor) normally reduces aldosterone release via blocking angiotensin II, but in primary aldosteronism, aldosterone is secreted autonomously (independent of the renin-angiotensin system). This explains why the ACE inhibitor fails to fully control hypertension.  \n- Hydrochlorothiazide (thiazide diuretic) may worsen hypokalemia, but the underlying issue is excess aldosterone driving both hypertension and electrolyte abnormalities.  \n\n\n**Answer: Primary aldosteronism (Conn syndrome)**.  \n\n(Note: The chunks confirm that restricted aldosterone release is a therapeutic effect (Chunk308), but the patient’s presentation reflects the opposite—uncontrolled aldosterone secretion as the root cause.)\n\n\n\\boxed{Primary aldosteronism}",
    "expected_answer": "Aldosterone excess",
    "time": 21.260577917099,
    "answer_length": 1368,
    "retrieval_time": 0.13277602195739746,
    "generation_time": 21.23402190208435
  },
  {
    "question": "A 65-year-old man comes to the physician because of a 1-week history of yellowish discoloration of his skin and generalized pruritus. Examination shows jaundice of the skin and scleral icterus. Urinalysis shows an elevated concentration of bilirubin and a low concentration of urobilinogen. Which of the following is the most likely underlying cause of these findings?",
    "answer": "The clinical findings (jaundice, pruritus, elevated urine bilirubin, low urine urobilinogen) are classic for **extrahepatic biliary obstruction**. This occurs when the flow of conjugated bilirubin into the gastrointestinal tract is blocked (e.g., by a pancreatic head adenocarcinoma, choledocholithiasis). Conjugated bilirubin backs up into the bloodstream (causing jaundice), is excreted in urine (elevated urine bilirubin), and reduced gut bilirubin leads to low urobilinogen production. Pruritus results from accumulated bile salts in the skin.\n\nWhile the provided chunks do not directly reference this cause, the question relies on standard pathophysiological associations for these findings. \n\n**Answer:** Extrahepatic biliary obstruction (e.g., pancreatic head carcinoma or choledocholithiasis). Given the patient's age (65-year-old man), pancreatic head adenocarcinoma is a particularly likely underlying cause.\n\n\n(Note: If constrained to the provided chunks, none directly address the question. However, the clinical scenario demands the standard pathophysiological answer as above.)",
    "expected_answer": "Defective hepatic bile excretion",
    "time": 19.510476112365723,
    "answer_length": 1091,
    "retrieval_time": 0.043189048767089844,
    "generation_time": 19.480834007263184
  },
  {
    "question": "A 72-year-old woman is brought to the physician by her daughter because of a 6-month history of worsening short-term memory deficits and social withdrawal. Treatment with galantamine is initiated. Two weeks later, the patient develops vomiting, mild crampy abdominal pain, and watery, nonbloody diarrhea. Which of the following is the most appropriate pharmacotherapy?",
    "answer": "To address the patient’s symptoms (vomiting, abdominal cramps, diarrhea), we first recognize these as **cholinergic side effects** of galantamine, a cholinesterase inhibitor that increases acetylcholine levels. Cholinergic excess is countered by **antimuscarinic agents** (anticholinergics), which block muscarinic receptors to mitigate these GI and autonomic symptoms.\n\n\n### Key Reasoning:\n- Galantamine’s side effects stem from increased acetylcholine (cholinergic excess).  \n- The most appropriate pharmacotherapy for cholinergic toxicity/side effects is an **antimuscarinic drug** like **atropine**, which reverses muscarinic effects (e.g., GI hypermotility, vomiting).  \n\n\n**Answer: Atropine** (or another antimuscarinic agent, but atropine is the standard choice here).  \n\n(Note: While the provided chunks do not explicitly mention this, the question relies on standard clinical knowledge of cholinergic side effect management, as the given chunks lack direct relevant data for this scenario.)\n\n\n\\boxed{Atropine}",
    "expected_answer": "Atropine",
    "time": 21.998252153396606,
    "answer_length": 1018,
    "retrieval_time": 0.04538917541503906,
    "generation_time": 21.97320008277893
  },
  {
    "question": "A 61-year-old man with schizophrenia in a locked inpatient psychiatry unit was observed making an unusual smacking motion with his lips, pursing his mouth, and blinking excessively. These symptoms started slowly about 2 weeks ago and have become more pronounced, but they do not seem to bother the patient. He resides in an inpatient psychiatric facility where he has been successfully treated with haloperidol for the past several months. His physical exam and vitals are within normal limits. Which of the following accurately describes his symptoms?",
    "answer": "To determine the correct description of the patient’s symptoms, we analyze the key details from the scenario:  \n\n### Key Observations:  \n- The patient is a 61-year-old man with schizophrenia, treated with **haloperidol** (a typical antipsychotic) for several months.  \n- He developed involuntary symptoms: lip smacking, mouth pursing, excessive blinking—onset 2 weeks ago, worsening, and not distressing to him.  \n\n\n### Diagnosis:  \nThese symptoms are classic for **tardive dyskinesia (TD)**. TD is a late-onset movement disorder caused by long-term use of antipsychotics (especially typical agents like haloperidol). It is characterized by repetitive, involuntary movements, most commonly of the face (orofacial dyskinesia: lip smacking, tongue protrusion, blinking).  \n\nOther movement disorders from antipsychotics (acute dystonia, akathisia, parkinsonism) typically onset earlier (hours to days/weeks) and present with different symptoms (dystonic posturing, restlessness, bradykinesia/rigidity, respectively), which do not match this case.  \n\n\n**Answer: Tardive dyskinesia** (this would be the correct option in a standard question setup).  \n\n(Note: If options were provided, the choice corresponding to tardive dyskinesia is the right answer.)",
    "expected_answer": "Tardive dyskinesia",
    "time": 23.20479679107666,
    "answer_length": 1248,
    "retrieval_time": 0.04494881629943848,
    "generation_time": 23.192742824554443
  },
  {
    "question": "A 17-year-old football player with no significant past medical history, social history, or family history presents to his pediatrician with itching in his groin. He says this started during summer workouts leading up to this season. He denies having any rash anywhere else on his body. The blood pressure is 123/78 mm Hg, pulse is 67/min, respiratory rate is 15/min, and temperature is 38.1°C (98.7°F). Physical examination reveals an erythematous, well-demarcated patch with peripheral scale on the left thigh, pubic region, and perineum. There is no apparent scrotal involvement with the rash. How can you confirm the suspected diagnosis?",
    "answer": "To confirm the suspected diagnosis (likely tinea cruris, a fungal infection common in athletes in warm, moist areas), the appropriate test is **KOH examination of lesion scrapings** (from Chunk 55). This test identifies fungal elements (hyphae) in skin scrapings, which confirms a dermatophyte infection like tinea cruris.\n\n\nAnswer: KOH examination of lesion scrapings.",
    "expected_answer": "KOH examination of lesion scrapings",
    "time": 10.87294316291809,
    "answer_length": 369,
    "retrieval_time": 0.04367804527282715,
    "generation_time": 10.845195055007935
  },
  {
    "question": "An otherwise healthy 26-year-old man comes to the physician for medication counseling after recently being diagnosed with schizophrenia. Risperidone therapy is initiated. This patient is at increased risk for which of the following adverse effects?",
    "answer": "To determine the increased risk of adverse effects with risperidone therapy in this patient, we analyze the pharmacology and key adverse effects of risperidone:\n\n\n### Key Background on Risperidone  \nRisperidone is an **atypical antipsychotic** that acts as a serotonin-dopamine antagonist (blocks D₂ and 5-HT₂A receptors). A critical effect of D₂ receptor blockade occurs in the **tuberoinfundibular pathway**: normally, D₂ receptors inhibit prolactin release. Blocking these receptors removes this inhibition, leading to **hyperprolactinemia**.\n\n\n### Clinical Manifestations of Hyperprolactinemia in Men  \nIn an otherwise healthy 26-year-old man, hyperprolactinemia from risperidone can cause:  \n- Gynecomastia (breast tissue enlargement)  \n- Galactorrhea (abnormal milk production)  \n- Sexual dysfunction (e.g., erectile dysfunction, decreased libido)  \n- Reduced spermatogenesis (infertility in severe cases)  \n\n\n### Other Possible Effects (Less Specific to Risperidone)  \nWhile extrapyramidal symptoms (EPS) or weight gain are possible, hyperprolactinemia is a **distinctive adverse effect** of risperidone (more prominent than in other atypicals like quetiapine or aripiprazole).\n\n\n**Answer:** Hyperprolactinemia (or its clinical manifestation, e.g., gynecomastia).  \n\nFor a USMLE-style context, the most likely answer choice would be **hyperprolactinemia** or **gynecomastia** (a direct result of hyperprolactinemia).\n\n\n\\boxed{Hyperprolactinemia}  \n\n(Note: If the original question included options like \"gynecomastia,\" that would also be correct as a manifestation of hyperprolactinemia.)",
    "expected_answer": "Gynecomastia",
    "time": 35.10299491882324,
    "answer_length": 1595,
    "retrieval_time": 0.09684300422668457,
    "generation_time": 35.08070087432861
  },
  {
    "question": "A 15-year-old woman presents with fever, altered mental status and a petechial rash on her lower extremities and back since yesterday evening. She also says she has been nauseous for the past 3 hours and has vomited twice. The patient mentions she has had heavy menstrual bleeding for the past few days. Her blood pressure is 95/80 mm Hg and her temperature is 40.0°C (104.0°F). On physical examination, the patient appears diaphoretic. A pelvic examination reveals a tampon in her vagina. Binding and activation of which of the following T cell receptors is responsible for this patient’s most likely condition?",
    "answer": "To solve this question, we first identify the patient’s condition and then link it to the relevant T cell receptor component.\n\n\n### Step 1: Identify the patient’s condition  \nThe patient presents with **high fever (40°C)**, altered mental status, petechial rash, hypotension, GI symptoms (nausea/vomiting), and a tampon in the vagina. These findings are classic for **toxic shock syndrome (TSS)**, caused by superantigens from *Staphylococcus aureus*.\n\n\n### Step 2: Mechanism of TSS  \nSuperantigens bind to the **variable β-sequence of the T cell receptor (TCR Vβ region)** and MHC class II molecules (outside the antigen-binding groove). This cross-linking activates a large fraction of T cells, leading to massive cytokine release and systemic symptoms.\n\n\n### Step 3: Match to the provided chunks  \nChunk 57 explicitly references the **Variable β-sequence of the T cell receptor**, which is the key component involved in TSS pathogenesis.\n\n\n**Answer:** Variable β-sequence of the T cell receptor (Chunk 57)  \n\n\\boxed{Variable β-sequence of the T cell receptor}",
    "expected_answer": "Variable β-sequence of the T cell receptor",
    "time": 16.26228904724121,
    "answer_length": 1062,
    "retrieval_time": 0.04659414291381836,
    "generation_time": 16.23550510406494
  },
  {
    "question": "A 2-year-old boy is brought to the physician for evaluation of pallor and increasing lethargy for 2 days. One week ago, he experienced abdominal pain, vomiting, and bloody diarrhea that have since subsided. The patient's father states that they returned early from a 6-week roadtrip in Mexico because of these symptoms. His parents have been giving him oral rehydration solution. His immunizations are up-to-date. He appears pale. His temperature is 38.4°C (101.1°F), pulse is 130/min, respirations are 35/min, and blood pressure is 95/50 mm Hg. Examination shows scleral icterus. The abdomen is soft and nontender; there is no rebound or guarding. Bowel sounds are hyperactive. The remainder of the examination shows no abnormalities. Laboratory studies show:\nHemoglobin 8.5 g/dL\nMean corpuscular volume 94 μm3\nLeukocyte count 18,000/mm3\nPlatelet count 45,000/mm3\nProthrombin time 12 sec\nPartial thromboplastin time 34 sec\nSerum\nUrea nitrogen 28 mg/dL\nCreatinine 1.6 mg/dL\nBilirubin\nTotal 2.5 mg/dL\nDirect 0.1 mg/dL\nLactate dehydrogenase 1658 U/L\nA blood smear shows schistocytes. Which of the following is the most likely diagnosis?\"",
    "answer": "The most likely diagnosis is **Hemolytic Uremic Syndrome (HUS)**.\n\n\n### Key Reasoning:  \nThe patient presents with a classic triad of findings consistent with diarrhea-associated HUS (D+ HUS), the most common form in children:  \n1. **Microangiopathic Hemolytic Anemia**: Normocytic anemia (Hb 8.5 g/dL), indirect hyperbilirubinemia (total bilirubin 2.5 mg/dL, direct 0.1 mg/dL), elevated LDH (1658 U/L), and schistocytes on blood smear (fragmented RBCs, indicative of MAHA).  \n2. **Thrombocytopenia**: Platelet count 45,000/mm³ (low, without coagulopathy—PT/PTT normal, ruling out DIC).  \n3. **Acute Kidney Injury**: Elevated BUN (28 mg/dL) and creatinine (1.6 mg/dL).  \n\nAdditionally, the patient has a preceding history of **bloody diarrhea** (a hallmark of D+ HUS, typically caused by pathogens like *E. coli O157:H7* or *Shigella*), and recent travel to Mexico (a setting where exposure to such pathogens is possible).\n\n\n**Answer:** Hemolytic Uremic Syndrome (HUS)",
    "expected_answer": "Hemolytic uremic syndrome",
    "time": 19.924171924591064,
    "answer_length": 968,
    "retrieval_time": 0.053125858306884766,
    "generation_time": 19.895210027694702
  },
  {
    "question": "A 17-year-old girl is referred by her dentist for a suspected eating disorder. She has been visiting the same dentist since childhood and for the past 2 years has had at least 2 visits for dental caries. She eventually admitted to him that she regularly induces vomiting by putting her fingers down her throat. She says she has been doing this for the last few years and purging at least once a week. More recently, she has been inducing emesis more often and even looked into diuretics as she feels that she is gaining more and more weight compared to her ‘skinny friends’. Her BMI is at the 50th percentile for her age and sex. Which of the following features is most consistent with this patient’s condition?",
    "answer": "To answer the question, we first analyze the patient’s presentation and identify her likely condition, then match it to the provided information:\n\n\n### Step 1: Diagnose the patient’s eating disorder  \nThe 17-year-old girl has **recurrent purging behaviors** (self-induced vomiting, consideration of diuretics) to prevent weight gain, frequent dental caries (a complication of vomiting due to acid erosion), and a **normal BMI** (50th percentile). These features are consistent with **bulimia nervosa** (characterized by compensatory purging, normal/slightly elevated BMI, and comorbid mood symptoms).\n\n\n### Step 2: Match to provided information  \nAmong the chunks, **Chunk 1209 (Affective symptoms)** is most consistent with bulimia nervosa. Affective symptoms (e.g., depression, anxiety) are highly comorbid with eating disorders like bulimia, reflecting the emotional distress often associated with the condition.\n\n\n**Answer: Affective symptoms**",
    "expected_answer": "Patients with this disorder are not further sub-typed",
    "time": 16.688090324401855,
    "answer_length": 948,
    "retrieval_time": 0.046051740646362305,
    "generation_time": 16.660043001174927
  },
  {
    "question": "A 14-year-old girl is brought to the physician by her father because of fever, chills, abdominal pain, and profuse non-bloody diarrhea. Her symptoms began one week ago, when she had several days of low-grade fever and constipation. She returned from Indonesia 2 weeks ago, where she spent the summer with her grandparents. Her temperature is 39.3°C (102.8°F). Examination shows diffuse abdominal tenderness and mild hepatosplenomegaly. There is a faint salmon-colored maculopapular rash on her trunk and abdomen. Which of the following is the most likely causal organism?",
    "answer": "To determine the most likely causal organism, we analyze the key clinical and epidemiological clues:\n\n\n### **Key Clues from the Case**  \n- **Travel history**: Indonesia (tropical region, high risk for typhoid fever).  \n- **Symptoms**:  \n  - Initial constipation → later non-bloody diarrhea.  \n  - High fever (39.3°C), abdominal tenderness, mild hepatosplenomegaly.  \n  - **Salmon-colored maculopapular rash** (rose spots) on trunk/abdomen.  \n- **Incubation period**: Returned 2 weeks ago, symptoms started 1 week ago (consistent with typhoid’s 1–3 week incubation).  \n\n\n### **Classic Association**  \nThe salmon-colored maculopapular rash (rose spots), combined with constipation → diarrhea, fever, hepatosplenomegaly, and travel to a typhoid-endemic area, is **pathognomonic for typhoid fever**, caused by **Salmonella enterica serotype Typhi** (or *Salmonella Typhi*).  \n\n\n**Answer: Salmonella enterica serotype Typhi** (or simply *Salmonella Typhi*).  \n\n\\boxed{Salmonella\\ Typhi}",
    "expected_answer": "Salmonella typhi",
    "time": 15.263802766799927,
    "answer_length": 981,
    "retrieval_time": 0.04594016075134277,
    "generation_time": 15.237366199493408
  },
  {
    "question": "A 22-year-old female college student is treated with metronidazole after presenting to student health services with itching, discharge, and pain in her vagina. At a party shortly afterward she experiences facial flushing, nausea, tachycardia, dyspnea, headache, and abdominal cramps after consuming alcohol. Serum levels of which of the following are likely elevated in this patient following alcohol consumption:",
    "answer": "To determine the elevated serum level, we analyze the interaction between metronidazole and alcohol:  \n\nMetronidazole inhibits **aldehyde dehydrogenase (ALDH)**, an enzyme critical for metabolizing acetaldehyde (a toxic byproduct of alcohol breakdown). Normally, ethanol → acetaldehyde (via alcohol dehydrogenase) → acetate (via ALDH). When ALDH is blocked, acetaldehyde accumulates, causing the observed symptoms (flushing, nausea, tachycardia, etc.)—a disulfiram-like reaction.  \n\n\n**Answer: Acetaldehyde**",
    "expected_answer": "Acetaldehyde",
    "time": 6.21818208694458,
    "answer_length": 508,
    "retrieval_time": 0.10767531394958496,
    "generation_time": 6.191313028335571
  },
  {
    "question": "A 23-year-old primigravida presents for a regular prenatal care visit at 16 weeks gestation. She complains of increased fatigability, but is otherwise well. She takes folic acid, iron, and vitamin D supplementation. Her vital signs are as follows: blood pressure, 110/70 mm Hg; heart rate, 86/min; respiratory rate, 13/min; and temperature, 36.6℃ (97.9℉). The physical examination is unremarkable. The complete blood count results are as below:\nErythrocyte count 3.9 million/mm3\nHb 11.1 g/dL\nHCT 32%\nReticulocyte count 0.2%\nMCV 90 fL\nPlatelet count 210,000/mm3\nLeukocyte count 8,100/mm3\nWhich of the following tests is required to investigate the cause of the patient’s laboratory findings?",
    "answer": "To determine the required test, we analyze the patient’s lab findings and link them to the provided chunks:\n\n\n### Key Patient Findings  \n- **23-year-old primigravida (16 weeks gestation)**  \n- **CBC: Normocytic anemia (MCV=90fL), low reticulocyte count (0.2% → decreased RBC production), Hb=11.1g/dL (near second-trimester anemia cutoff)**  \n- **On folic acid and iron supplementation** (rules out common nutritional causes like iron/folate deficiency for this presentation).  \n\n\n### Relevant Chunk Analysis  \nChunk 1077 mentions **erythroblasts with mitochondrial iron deposits**—this describes **ring sideroblasts**, a hallmark of sideroblastic anemia. Sideroblastic anemia causes hypoproliferative normocytic anemia (consistent with the patient’s low reticulocytes and normal MCV).  \n\n\n### Required Test  \nThe test to detect ring sideroblasts is **bone marrow aspiration with Prussian blue staining** (to visualize mitochondrial iron deposits in erythroblasts).  \n\n\n**Answer:** Bone marrow aspiration and Prussian blue staining to identify erythroblasts with mitochondrial iron deposits (ring sideroblasts).  \n\n(Note: Since the question asks for the test, the answer aligns with the finding in Chunk 1077.)  \n\n\\boxed{Bone marrow aspiration with Prussian blue staining}",
    "expected_answer": "No tests required",
    "time": 29.831284046173096,
    "answer_length": 1271,
    "retrieval_time": 0.04958987236022949,
    "generation_time": 29.803905963897705
  },
  {
    "question": "An 80-year-old man is transferred from a step-down unit to a med-surg floor in the hospital. He had undergone a successful hernia surgery 14 hours ago. Before the surgery, he was pre-treated with atropine, scopolamine, and morphine and recovered well in the PACU after the surgery. There were no complications in the step-down unit and the patient continued to recover. On the med-surg floor, his temperature is 36.8°C (98.2°F), the heart rate is 98/min, the respiratory rate is 15/min, the blood pressure is 100/75 mm Hg, the oxygen saturation is 90%. On physical exam, he is a well-developed, obese man. His heart has a regular rate and rhythm and his lungs are clear to auscultation bilaterally. His incision site is clean, dry, and intact with an appropriate level of swelling and erythema. During the physical, the patient mentions some discomfort in his abdomen and pelvis and during a records review it is noted that he has not passed urine in the PACU, step-down unit, or since arriving on the med-surg floor. A bladder scan is inconclusive due to body habitus. What is the next best step in the treatment of this patient?",
    "answer": "Insert a 'straight cath' into the patient’s bladder.  \n\n### Rationale:  \nThe patient has post-operative urinary retention (no urine output since surgery, likely due to anticholinergic meds like atropine/scopolamine and opioids like morphine which impair bladder function). A bladder scan is inconclusive due to obesity, so straight catheterization is the next best step to empty the bladder and confirm retention. This aligns with Chunk 63. Other chunks are irrelevant: no indication for resuscitation (Chunk474), cardioversion (Chunk475), or avoiding tests (Chunk62); the anesthetic adverse effect (Chunk1114) is a possible cause but not the immediate treatment.\n\n\n**Answer:** Insert a 'straight cath' into the patient’s bladder.",
    "expected_answer": "Insert a ‘straight cath’ into the patient’s bladder",
    "time": 13.112748146057129,
    "answer_length": 730,
    "retrieval_time": 0.05208110809326172,
    "generation_time": 13.08596920967102
  },
  {
    "question": "A healthy 19-year-old man presents to his primary care provider complaining of painless “blisters” in his mouth. He reports that he noticed a white film on his tongue and the sides of his mouth 2 days ago while brushing his teeth. The film was easily brushed off. He also complains of a bitter metallic taste in his mouth but otherwise denies pain, burning, dysphagia, or hoarseness. He is otherwise healthy and takes no medications. He is a competitive swimmer and has had 8 sexual partners in the past year. He intermittently uses barrier protection. On exam, he is well-appearing and in no acute distress. His oral examination demonstrates patches of white pseudomembranes that can be wiped away to reveal erythematous mucosa. A medication with which of the following mechanisms of action is most appropriate in this patient?",
    "answer": "To answer this question, we first diagnose the patient’s condition, then identify the appropriate medication mechanism.\n\n\n### Step 1: Diagnose the Condition  \nThe patient presents with:  \n- White oral pseudomembranes easily wiped away to reveal erythematous mucosa  \n- Bitter metallic taste  \n- No pain/burning  \n\nThese findings are **classic for oral candidiasis (thrush)** (Candida albicans infection). Key clues: scrapable white plaques with underlying redness (distinguishes from leukoplakia/lichen planus, where plaques are not easily removed).\n\n\n### Step 2: Identify Appropriate Medication Mechanism  \nOral thrush is treated with antifungals. Common options include:  \n- **Azoles (fluconazole, clotrimazole):** Inhibit lanosterol 14-α-demethylase, an enzyme critical for fungal ergosterol synthesis (ergosterol is essential for fungal cell membrane integrity).  \n- **Polyenes (nystatin):** Bind to ergosterol in fungal membranes, forming pores that cause cell lysis.  \n\nThe most frequently tested mechanism for oral thrush treatment (especially systemic azoles like fluconazole) is **inhibition of fungal ergosterol biosynthesis**.\n\n\n**Answer:** Inhibition of fungal ergosterol synthesis (or similar wording reflecting this mechanism).  \n\n(Note: The provided chunks do not directly contain this info, but the clinical scenario requires applying standard knowledge of oral candidiasis treatment.)\n\n\n\\boxed{Inhibition of fungal ergosterol biosynthesis}",
    "expected_answer": "Disruption of cell membrane permeability",
    "time": 34.82505416870117,
    "answer_length": 1456,
    "retrieval_time": 0.04649615287780762,
    "generation_time": 34.801920890808105
  },
  {
    "question": "A 56-year-old man presents to the clinic complaining of subacute back pain for the past month. The pain is described as a dull, constant ache that is worse at night. He could not recall any precipitating event except for an amateur weight-lifting competition that he participated in 2 months ago. Past medical history is significant for non-small cell lung cancer that was diagnosed and successfully treated. A PET scan 1 year ago demonstrated no recurrence. Physical exam was unremarkable except for some point tenderness along the lumbosacral area. What is the most likely imaging finding in this patient?",
    "answer": "Lytic lesions of the lumbar spine\n\nThe patient has a history of non-small cell lung cancer (a common source of metastatic bone disease) and presents with subacute back pain worse at night and lumbosacral point tenderness—classic red flags for metastatic bone lesions. Lung cancer metastases to bone are often lytic, which aligns with the finding in Chunk 65. The other chunks refer to imaging tests (PET of chest, MRI of brain and spine) rather than specific imaging findings.\n\n\n**Answer:** Lytic lesions of the lumbar spine",
    "expected_answer": "Lytic lesions of the lumbar spine",
    "time": 8.454622983932495,
    "answer_length": 524,
    "retrieval_time": 0.04957699775695801,
    "generation_time": 8.429164171218872
  },
  {
    "question": "A 4-year-old boy is brought to the emergency department because of severe abdominal pain and bilious vomiting for 6 hours. He has not had bowel movements in the past 24 hours. He appears ill. His temperature is 37.8°C (100°F) and pulse is 122/min. Examination shows a distended abdomen. There is tenderness to palpation in the lower abdomen; guarding and rebound tenderness are present. Bowel sounds are decreased. An x-ray of the abdomen shows dilated loops of bowel. He has been accompanied by his 14-year-old brother. The surgeon recommends an emergency laparotomy. The parents are away visiting friends and cannot be reached. Which of the following is the most appropriate next best step in management?",
    "answer": "The most appropriate next step in management is to perform the emergency laparotomy (as indicated in Chunk 66).  \n\nThis child presents with clear signs of a surgical emergency (severe abdominal pain with guarding/rebound, bilious vomiting, dilated bowel loops on imaging) requiring immediate intervention to prevent life-threatening complications (e.g., bowel ischemia, perforation). Since the parents are unreachable and delay in treatment would pose significant harm to the child, implied consent for emergency care applies. The 14-year-old brother is a minor and cannot provide legal consent, so proceeding with the recommended emergency laparotomy is the necessary action to address the urgent surgical need.\n\n\n**Answer:** Perform emergency laparotomy (Chunk 66)  \n(Note: Expanded explanation aligns with ethical/legal principles of implied consent in pediatric emergencies when caregivers are unavailable and delay risks harm.)",
    "expected_answer": "Perform emergency laparotomy",
    "time": 18.066079139709473,
    "answer_length": 932,
    "retrieval_time": 0.09919118881225586,
    "generation_time": 18.038701057434082
  },
  {
    "question": "A 3-week-old male newborn is brought to the hospital because of poor weight gain since birth. He was born at 38 weeks' gestation via normal vaginal delivery. He weighed 3005 g (6 lb, 10 oz) at birth and currently weighs 2835 g (6 lb, 4 oz). He has been latching on and breastfeeding well since birth. His mother has a history of Graves' disease and underwent near-total thyroidectomy in the second trimester of her pregnancy after her symptoms could not be controlled with antithyroid drugs. She is currently receiving L-thyroxine therapy. The patient's temperature is 38.9°C (102°F), pulse is 176/min, and respirations are 42/min. He appears irritable. Examination shows a diaphoretic infant with a paucity of subcutaneous fat. There is swelling of the neck at the midline. Which of the following is the most likely cause?",
    "answer": "To determine the most likely cause, we analyze the key clinical features and maternal history:\n\n\n### **Key Clinical Findings**  \n- 3-week-old newborn with **poor weight gain** (despite adequate breastfeeding), **fever**, **tachycardia**, **irritability**, **diaphoresis**, and **midline neck swelling**.  \n- Maternal history: Graves’ disease (autoimmune hyperthyroidism) treated with **near-total thyroidectomy** in the second trimester (but autoimmune antibodies like thyroid-stimulating immunoglobulin [TSI] can persist and cross the placenta).  \n\n\n### **Diagnostic Reasoning**  \nNeonatal Graves’ disease occurs when maternal TSI (from Graves’ disease) crosses the placenta, stimulating the fetal thyroid gland. This leads to:  \n- **Hypermetabolic state**: Tachycardia, fever, irritability, diaphoresis, and poor weight gain (due to increased energy expenditure).  \n- **Goiter**: Midline neck swelling from thyroid gland hyperplasia.  \n\nNone of the provided chunks directly mention neonatal Graves’ disease, but this is the classic diagnosis for the described clinical scenario.\n\n\n**Answer: Neonatal Graves' disease** (Note: This is the correct clinical diagnosis, even if not explicitly listed in the provided chunks, as it aligns perfectly with the patient’s presentation and maternal history.)  \n\n(If restricted to the given chunks, none directly fit; however, the clinical scenario overwhelmingly points to neonatal Graves’ disease.)  \n\n\\boxed{Neonatal Graves' disease}",
    "expected_answer": "Transplacental passage of TSH receptor antibodies",
    "time": 43.424094915390015,
    "answer_length": 1475,
    "retrieval_time": 0.05447506904602051,
    "generation_time": 43.40836000442505
  },
  {
    "question": "A 57-year-old female with a past medical history of alcoholism presents to the emergency room vomiting bright red blood. She is accompanied by her partner, who reports that she had been complaining of black and tarry stools for the past several days. Vital signs are temperature 37 degrees celsius, heart rate 141 beats per minute, blood pressure 90/60, respiratory rate 20, and oxygen saturation 99% on room air. On physical examination, she has splenomegaly and a positive fluid wave. The remainder of her examination is within normal limits. The patient is stabilized with intravenous fluids, and her blood pressure improves. Subsequent emergent upper endoscopy reveals bleeding from the submucosal veins in the lower 1/3 of the esophagus, but no gastric bleed. In the endoscopy suite she also receives IV octreotide. After intervention and resolution of her acute bleed, which of the following pharmacologic agents is indicated?",
    "answer": "To determine the indicated pharmacologic agent after resolving the acute bleed, we first analyze the case:  \n\nThe patient has alcoholism, portal hypertension (splenomegaly, fluid wave), and esophageal variceal bleeding (submucosal vein bleeding in the lower esophagus). For **secondary prevention of recurrent variceal bleeding** (after acute resolution), the standard pharmacologic intervention is **non-selective beta-blockers** (e.g., propranolol, nadolol). These agents reduce portal pressure by decreasing cardiac output (beta-1 blockade) and causing splanchnic vasoconstriction (unopposed alpha-1 activity due to beta-2 blockade), thereby lowering the risk of future variceal rupture.  \n\nAnswer: Propranolol (or another non-selective beta-blocker like nadolol).  \n\n(Note: While the provided chunks do not explicitly mention this agent, the answer aligns with standard clinical guidelines for secondary prevention of esophageal variceal bleeding in cirrhosis.)  \n\n\\boxed{Propranolol}",
    "expected_answer": "Nadalol",
    "time": 20.992346048355103,
    "answer_length": 988,
    "retrieval_time": 0.048897743225097656,
    "generation_time": 20.964139938354492
  },
  {
    "question": "A 65-year-old man with a history of hypertension, obesity, and alcoholic cirrhosis is seen in clinic for follow-up. He feels well and currently drinks 5 glasses of wine each night. Medications include atenolol and lisinopril. On physical exam, temperature is 98.1 deg F (36.7 deg C), blood pressure is 151/82 mmHg, pulse is 71/min, and respirations are 14/min. He has spider angiomata on his chest; no asterixis, jaundice, ascites, or peripheral edema is noted. Screening ultrasound reveals a new liver nodule, and follow up CT demonstrates a 2 cm right hepatic lobe lesion with enhancement in the arterial phase. No hypodense attenuation is seen on the venous or delayed phase. What is the next step in management?",
    "answer": "Proceed with liver biopsy\n\nThe patient has a 2 cm liver nodule in the setting of alcoholic cirrhosis. While arterial enhancement on CT is a feature of hepatocellular carcinoma (HCC), the absence of hypodensity (washout) in the venous or delayed phase is not diagnostic of HCC. For nodules of this size with non-typical imaging findings for HCC, the next step is to confirm the diagnosis via liver biopsy, as indicated in Chunk 69. Other provided chunks (Nadalol for variceal management, primary biliary cirrhosis) are not relevant to the current question of evaluating the liver nodule.\n\n\n**Answer:** Proceed with liver biopsy",
    "expected_answer": "Proceed with liver biopsy",
    "time": 13.890410900115967,
    "answer_length": 626,
    "retrieval_time": 0.049056053161621094,
    "generation_time": 13.86161494255066
  },
  {
    "question": "A 66-year-old man is brought to the emergency room by his wife due to abdominal distension and persistent somnolence for the past 2 weeks. The patient’s wife says that he has been sleeping much more than usual for the past 5 days. His bowel and bladder habit have not changed. His past medical history is significant for alcoholic liver cirrhosis. His vital signs include: pulse 76/min, respiratory rate 15/min, temperature 38.0°C (100.4°F) and blood pressure 122/75 mm Hg. On physical examination, the patient is altered and not responsive to commands. Oriented x 0. The abdomen is significantly distended. Shifting dullness is present and a positive fluid wave can be elicited. Hyperreflexia and asterixis are noted. Laboratory findings are significant for the following:\nLaboratory test\nSodium 140 mEq/L\nPotassium 3.5 mEq/L\nChloride 97 mEq/L\nGlucose 90 mg/dL\nAmmonia 100 µg/dL (ref: 19-60 µg/dL)\nArterial blood gas\npH 7.4\npCO2 40 mm Hg\npO2 90 mm Hg\nHCO3 26 mEq/L\nAn abdominal ultrasound shows surface nodularity compatible with cirrhosis but no other changes aside from ascites. An upper GI endoscopy is performed which shows gastric varices with no signs of active bleeding. An MRI of the brain is insignificant. What is the most likely precipitating factor that led to this patient’s condition?",
    "answer": "To determine the most likely precipitating factor for the patient’s condition, we first identify his clinical syndrome: **hepatic encephalopathy (HE)**. Key features supporting HE include:  \n- Alcoholic liver cirrhosis (underlying liver dysfunction)  \n- Altered mental status (oriented x0, somnolence)  \n- Asterixis and hyperreflexia  \n- Elevated ammonia level (100 µg/dL, above reference range)  \n\n\n### Common Precipitants of Hepatic Encephalopathy  \nThe most frequent triggers of HE in cirrhotic patients include infection (especially spontaneous bacterial peritonitis, SBP), gastrointestinal bleeding, electrolyte imbalances, and constipation.  \n\nFrom the case:  \n- The patient has a fever (38.0°C/100.4°F), indicating infection.  \n- He has ascites (abdominal distension, shifting dullness, fluid wave), a major risk factor for **spontaneous bacterial peritonitis (SBP)**—a common infection in cirrhotic patients with ascites and a leading precipitant of HE.  \n\nOther factors (e.g., GI bleeding, severe electrolyte imbalance) are ruled out:  \n- Upper GI endoscopy shows no active bleeding from varices.  \n- Electrolytes (sodium, potassium) and acid-base status are normal.  \n\n\n**Answer:** Spontaneous bacterial peritonitis (infection) is the most likely precipitating factor.  \n\n(Note: While the provided chunks do not directly mention SBP, the case’s fever and ascites—hallmarks of SBP—are the critical clues here.)  \n\n\\boxed{Spontaneous bacterial peritonitis}",
    "expected_answer": "Spontaneous bacterial peritonitis",
    "time": 27.731531143188477,
    "answer_length": 1464,
    "retrieval_time": 0.048729896545410156,
    "generation_time": 27.704621076583862
  },
  {
    "question": "A 27-year-old man presents to the emergency department after a motor vehicle collision. The patient was the front seat unrestrained driver in a head on collision. The patient’s echocardiogram (ECG) is notable only for sinus tachycardia. His temperature is 99.5°F (37.5°C), blood pressure is 107/58 mmHg, pulse is 120/min, respirations are 17/min, and oxygen saturation is 98% on room air. The patient is given 2 liters of Ringer lactate solution and morphine. Initial workup demonstrates that the patient’s pulmonary capillary wedge pressure and troponins are elevated. The patient is currently complaining of chest pain. Physical exam is notable for an uncomfortable young man with bruising over his chest wall. Which of the following is the most likely diagnosis?",
    "answer": "The most likely diagnosis is cardiac contusion.  \n\n### Key Reasoning:  \nThe patient is an unrestrained front-seat driver in a head-on collision (high-risk for blunt chest trauma), presenting with chest pain, chest wall bruising, elevated troponins (myocardial injury), and elevated pulmonary capillary wedge pressure (suggesting impaired left ventricular function from trauma). These findings align with **cardiac contusion** (Chunk 71), a blunt myocardial injury caused by chest trauma, which commonly presents with nonspecific ECG changes (sinus tachycardia here), troponin elevation, and chest pain.  \n\nOther chunks are irrelevant to the diagnosis: Chunk926 is a treatment (CT angiography/oxygen), Chunk430 describes distributive shock (not present here), and Chunk431 is a diagnostic test (head MRI).  \n\n**Answer:** Cardiac contusion.",
    "expected_answer": "Cardiac contusion",
    "time": 15.201435804367065,
    "answer_length": 838,
    "retrieval_time": 0.17388391494750977,
    "generation_time": 15.173186779022217
  },
  {
    "question": "A 56-year-old man presents to the emergency department for progressively worsening fatigue, malaise, fever, and abdominal pain. He reports that his symptoms began approximately 1 week ago and he has noticed episodes of diarrhea. He recently started melatonin and magnesium supplementation in hopes of improving his sleep. Medical history is significant for alcohol use disorder that required multiple hospital admissions for management of acute pancreatitis and cirrhosis. He states that he occasionally injects heroin intravenously. Temperature is 100°F (37.8°C), blood pressure is 105/70 mmHg, pulse is 92/min, and respirations are 17/min. Physical examination is significant for scleral icterus, hepatomegaly, ascites, and diffuse abdominal tenderness. Laboratory testing is significant for leukocytosis and metabolic acidosis. A paracentesis is performed and he is admitted into the hospital to receive intravenous cefotaxime and albumin. Ascitic fluid analysis demonstrates a polymorphonuclear cell count of 280 cells/mm^3, serum-ascites albumin gradient of 1.3 g/dL, and a culture positive for Escherichia coli sensitive to cefotaxime and ceftriaxone. On hospital day 2, the nurse reports that the patient is oliguric in the setting of constant fluid intake. Physical examination is unchanged. Laboratory testing is significant for a serum sodium of 131 mEq/L and creatinine of 1.8 mg/dL (it was 0.9 mg/dL on admission). Urine studies are significant for a low urine sodium level, without evidence of blood or protein. Since the hospital admission, he has not been started on any new medications. Which of the following will be the best treatment option for this patient?",
    "answer": "To determine the best treatment option, we first analyze the patient’s clinical scenario and align it with the provided information chunks:\n\n\n### Key Clinical Findings on Hospital Day 2  \nThe patient has cirrhosis and was admitted for spontaneous bacterial peritonitis (SBP). On day 2, he develops **acute kidney injury (AKI)** (creatinine increased from 0.9 to 1.8 mg/dL) with oliguria and low urine sodium (suggesting prerenal or toxin-induced AKI). He recently started magnesium supplementation, and AKI can impair magnesium excretion, leading to hypermagnesemia (which may exacerbate fatigue/malaise).\n\n\n### Alignment with Provided Chunks  \n- **Chunk486**: For stridor (irrelevant—no stridor present).  \n- **Chunk713**: IV fluids + insulin (for DKA, no hyperglycemia noted here).  \n- **Chunk652**: Measure serum drug concentration (critical to check magnesium levels, as supplementation + AKI may cause hypermagnesemia).  \n\n\n**Answer: Measure serum drug concentration** (consistent with Chunk652).  \n\n\\boxed{Measure serum drug concentration}",
    "expected_answer": "Liver transplantation",
    "time": 35.460789918899536,
    "answer_length": 1045,
    "retrieval_time": 0.0477139949798584,
    "generation_time": 35.43288993835449
  },
  {
    "question": "A 29-year-old woman presents to the clinic after several months of weight loss. She noticed a 6.8 kg (15 lb) unintentional weight loss over the preceding several months. She has not changed her diet or exercise habits. She also reports feuding with her boyfriend over the temperature of their shared apartment, as she always feels warmer than he does. The vital signs include: heart rate 110/min and blood pressure 146/78 mm Hg. The physical exam is notable for warm and slightly moist skin. She also exhibits a fine tremor in her hands when her arms are outstretched. The urine pregnancy test is negative. Which of the following is the best single treatment option for this patient?",
    "answer": "To answer this question, we first diagnose the patient's condition using her clinical presentation, then identify the appropriate treatment based on standard medical knowledge (since the provided chunks do not directly address the condition or its management).\n\n\n### Step 1: Diagnosis  \nThe patient’s symptoms—unintentional weight loss, heat intolerance, tachycardia (110/min), warm moist skin, and fine tremor—are classic for **hyperthyroidism** (most likely Graves’ disease, the leading cause in young women).  \n\n\n### Step 2: Best Treatment Option  \nFor hyperthyroidism (Graves’ disease) in non-pregnant adults, the first-line pharmacologic treatment is **methimazole**. It is preferred over propylthiouracil (PTU) due to a lower risk of severe liver injury, except in the first trimester of pregnancy. Definitive options (radioactive iodine ablation or surgery) are considered later if pharmacotherapy fails or is contraindicated, but methimazole is the optimal initial single treatment.\n\n\n**Answer:** Methimazole.",
    "expected_answer": "Methimazole",
    "time": 27.64225721359253,
    "answer_length": 1017,
    "retrieval_time": 0.04564356803894043,
    "generation_time": 27.614290714263916
  },
  {
    "question": "A 21-year-old man comes to the physician because of pruritus and a hypopigmented rash on his upper body for 5 days. He first noticed the symptoms after returning from a business trip last week in the Bahamas. While he was there, he visited a couple of beaches and went hiking with some coworkers. The rash initially started as a single lesion on his upper back but since then has extended to his shoulders. He has a history of type 1 diabetes mellitus controlled with an insulin pump. He works as an office manager and has no known exposure to melanocytotoxic chemicals. He has been sexually active with three female partners over the past year and uses condoms inconsistently. He is 183 cm (6 ft) tall and weighs 80 kg (176 lb); BMI is 23.9 kg/m2. His temperature is 37.2°C (99°F), pulse is 78/min, and blood pressure is 130/84 mm Hg. A photograph of the rash is shown. One month ago, his hemoglobin A1C was 7.8%. Which of the following is most likely to confirm the diagnosis?",
    "answer": "To determine the most likely test to confirm the diagnosis, we analyze the patient's presentation and the provided information chunks:\n\n\n### Key Patient Features  \n- 21-year-old man with pruritic hypopigmented rash after tropical travel (Bahamas: beaches/hiking).  \n- No fever, normal vital signs, type 1 diabetes, inconsistent condom use.  \n\n\n### Relevant Chunk Analysis  \nThe only diagnostic test mentioned in the chunks is **serum antibodies against hemagglutinin** (Chunk 152). The other chunks (lesion color variation, previous suicide attempt) are not confirmatory tests.  \n\n\n### Conclusion  \nGiven the available information, the only test that can confirm the diagnosis is serum antibodies against hemagglutinin.\n\n\n**Answer:** Serum antibodies against hemagglutinin.",
    "expected_answer": "Potassium hydroxide preparation",
    "time": 22.216004133224487,
    "answer_length": 773,
    "retrieval_time": 0.04938387870788574,
    "generation_time": 22.186404943466187
  },
  {
    "question": "A 5-year-old female is brought to a speech therapist for continuing work on improving her communication skills. She is only able to verbalize two word sentences and has generalized developmental delay. When she was born it was noticed that she had a high pitched mewing cry and subsequent physical exam revealed microcephaly, prominent epicanthal folds, and a holosystolic murmur best heard in the left 5th intercostal space near the sternum. An abnormality of which of the following chromosomes is most likely responsible for this patient's disorder?",
    "answer": "To determine the chromosome abnormality responsible for the patient’s disorder, we analyze her key clinical features:  \n\n### Key Symptoms & Correlation  \nThe patient presents with:  \n- Generalized developmental delay (only 2-word sentences at 5 years).  \n- High-pitched \"mewing\" cry at birth (pathognomonic for cri-du-chat syndrome).  \n- Microcephaly, prominent epicanthal folds.  \n- Holosystolic murmur at the left 5th intercostal space near the sternum (likely a ventricular septal defect, common in this syndrome).  \n\n\n### Diagnosis  \nThese features are characteristic of **cri-du-chat syndrome**, caused by a deletion of the short arm of chromosome 5 (5p deletion).  \n\n\n**Answer: Chromosome 5** (specifically, a deletion of the short arm of chromosome 5).  \n\n\\boxed{5}",
    "expected_answer": "5",
    "time": 11.238614082336426,
    "answer_length": 772,
    "retrieval_time": 0.04596304893493652,
    "generation_time": 11.210163116455078
  },
  {
    "question": "A 62-year old female comes to the physician because of vaginal spotting and urinary urgency for the past 4 days. She has had no fever, abdominal pain, or diarrhea. Menopause occurred at 52 years of age. Her last Pap smear 1 year ago was normal. She has hypertension, hypercholesterolemia, and diabetes. Medications include atorvastatin, hydrochlorothiazide, metformin, and aspirin. She is sexually active with her husband. Her temperature is 37°C (98.6°F), pulse is 95/min, respirations are 12/min, and blood pressure is 155/65 mm Hg. Pelvic exam demonstrates a 4 x 3 cm firm, immobile erythematous mass on the right inner vaginal wall. Which of the following is the most appropriate next step in management?",
    "answer": "To determine the most appropriate next step, we analyze the case and the provided information:\n\n\n### Key Case Features  \nA 62-year-old postmenopausal woman presents with vaginal spotting and urinary urgency, plus a **4x3 cm firm, immobile erythematous vaginal wall mass**. She has no signs of infection (no fever, abdominal pain) and her last Pap smear was normal 1 year ago.  \n\n\n### Relevance of Provided Chunks  \n- **Chunk 8 (active/recurrent PID):** Irrelevant—she has no symptoms of PID (fever, pelvic pain).  \n- **Chunk 206 (LOD Score >3):** Genetic linkage score, not applicable to this clinical scenario.  \n- **Chunk207 (observation/screening):** For low-risk lesions (e.g., mild dysplasia), not a suspicious mass with bleeding.  \n\n\n### Standard Clinical Approach  \nA visible, firm vaginal mass in a postmenopausal woman with bleeding requires **tissue diagnosis** to rule out malignancy (e.g., vaginal cancer or metastasis). The only way to confirm the nature of the mass is to biopsy it.  \n\n\n**Answer:** Biopsy of the vaginal mass.  \n\n(Note: While the provided chunks do not explicitly mention biopsy, this is the standard next step for a suspicious vaginal mass with bleeding, as no other options from the chunks are relevant.)  \n\n\\boxed{Biopsy of the vaginal mass}",
    "expected_answer": "Biopsy of the mass",
    "time": 18.914155960083008,
    "answer_length": 1275,
    "retrieval_time": 0.10434579849243164,
    "generation_time": 18.885414123535156
  },
  {
    "question": "A 59-year-old man is evaluated for progressive joint pain. There is swelling and tenderness over the first, second, and third metacarpophalangeal joints of both hands. His hand radiograph is shown. He has had diabetes mellitus for 2 years which is not well controlled with medications. Lab studies show a transferrin saturation of 88% and serum ferritin of 1,200 ng/mL. Which of the following best represents the etiology of this patient condition?",
    "answer": "To determine the etiology of the patient’s joint condition, we analyze key clinical findings and link them to the provided information:\n\n\n### Key Patient Findings  \n- Progressive joint pain/swelling in MCP joints  \n- Markedly elevated transferrin saturation (88%) and ferritin (1200 ng/mL) → **iron overload** (consistent with hemochromatosis)  \n- Hemochromatosis causes iron deposition in joints, leading to arthropathy that often mimics degenerative joint disease.  \n\n\n### Analysis of Provided Chunks  \n- **Chunk1081**: Degenerative disease of the joints → Hemochromatosis-related arthropathy presents as degenerative joint changes due to iron deposition.  \n- **Chunk35**: Psoriatic arthritis → No skin symptoms or typical psoriatic joint features (e.g., dactylitis) are mentioned, and iron overload is not specific to this condition.  \n- **Chunk1201**: Iron deficiency → Opposite of the patient’s iron overload.  \n- **Others (34,1200)**: Unrelated to joint etiology (treatment/antibiotic).  \n\n\n**Answer**: Degenerative disease of the joints (Chunk1081)  \n\n\\boxed{Degenerative disease of the joints}",
    "expected_answer": "Deposition of calcium pyrophosphate (CPP) crystals",
    "time": 42.69934105873108,
    "answer_length": 1101,
    "retrieval_time": 0.04732489585876465,
    "generation_time": 42.67259907722473
  },
  {
    "question": "A newborn is found to be extremely cyanotic immediately after birth. He then develops progressive respiratory failure and is admitted to the neonatal ICU. A single loud S2 heart sound is appreciated as well as a machine-like murmur at the left upper sternal border. Radiography shows an enlarged \"egg-shaped\" heart. The newborn is then taken for a atrial septostomy to alleviate the condition pending definitive surgical correction. Which of the following is the most likely cause of this newborn's condition?",
    "answer": "To determine the most likely cause, we analyze the question clues and match them to the provided chunks:\n\n\n### Key Clues from the Question:  \n- Newborn with **immediate cyanosis** and progressive respiratory failure.  \n- **Atrial septostomy** performed (used for congenital heart defects requiring increased atrial blood mixing).  \n- The only heart-related option in the chunks is **Ventricular Septal Defect (VSD)** (Chunk1151).  \n\n\n### Elimination of Other Chunks:  \n- **Chunk30 (Obstruction of cystic duct):** Biliary issue (unrelated to heart).  \n- **Chunk31 (Increased ventricular wall stiffness):** Restrictive cardiomyopathy (not a newborn cyanotic defect).  \n- **Chunk1150 (No further intervention):** Not a cause of the condition.  \n\n\n### Conclusion:  \nThe only plausible heart-related cause in the chunks is **Ventricular Septal Defect (VSD)**. While isolated VSD is typically acyanotic, it may be part of a complex cyanotic defect (e.g., in combination with other anomalies) that requires atrial septostomy.  \n\n\n**Answer: Chunk1151 (Ventricular septal defect)**",
    "expected_answer": "Transposition of great vessels",
    "time": 24.53126621246338,
    "answer_length": 1072,
    "retrieval_time": 0.04843497276306152,
    "generation_time": 24.502291917800903
  },
  {
    "question": "A 25-year-old male involved in a knife fight presents with a penetrating wound to the chest. The patient is unconscious and cannot provide any further history. Vitals show a temperature of 37-0°C (98.6°F), blood pressure of 85/55 mm Hg, pulse of 115/min, respirations of 19/min, and oxygen saturation of 92% on room air. On physical examination, the patient is diaphoretic and unresponsive. Extremities are pale and cool. There is a 3-inch long penetrating wound between the 3rd and 4th intercostal space on the left side of the chest, which is bleeding profusely. Transthoracic echocardiography reveals a full thickness penetrating injury to the right ventricular free wall. There are no apparent injuries to any coronary arteries or major branches. The patient is intubated and aggressive fluid resuscitation is initiated, including a blood transfusion. Which of the following is the best definitive surgical approach to take in this patient?",
    "answer": "To determine the best definitive surgical approach for this patient with a full-thickness right ventricular free wall injury from a penetrating chest wound, we analyze the key clinical details and surgical principles:\n\n\n### Key Clinical Context  \nThe patient has a **penetrating cardiac injury** (right ventricular free wall, full-thickness) with hemodynamic instability (shock). Definitive repair requires surgical access that allows comprehensive exposure of the heart and surrounding structures to ensure thorough repair and rule out additional injuries.\n\n\n### Surgical Approach Rationale  \n- **Median sternotomy** is the gold standard for definitive repair of cardiac injuries. It provides excellent exposure to all four cardiac chambers, great vessels, and coronary arteries—critical for addressing the right ventricular injury and any potential associated damage (even if unidentifiable on echo).  \n- Anterolateral thoracotomy (left or right) is typically reserved for **emergency resuscitative scenarios** (e.g., cardiac arrest in the ER) but is not definitive, as it limits access to other chambers or structures.  \n- The left chest wound location does not dictate the definitive approach; the priority is optimal exposure of the injured chamber (right ventricle) and comprehensive assessment.\n\n\n**Answer: Median sternotomy**\n\n\n(Note: While the original question may have included options, the standard definitive surgical approach for this scenario is median sternotomy.)\n\n\n\\boxed{Median sternotomy}",
    "expected_answer": "Interrupted 2-0 polypropylene suture with supporting pledgets",
    "time": 22.530543088912964,
    "answer_length": 1508,
    "retrieval_time": 0.06589508056640625,
    "generation_time": 22.50471019744873
  },
  {
    "question": "A post-mortem lung examination of a 68-year-old male overweight male with evidence of chronic lower extremity edema, a 60 pack-year smoking history and daily productive cough would be most likely to reveal:",
    "answer": "To determine the most likely post-mortem lung finding, we analyze the patient’s clinical features and link them to the provided information:  \n\n### Key Patient Details:  \n- 60 pack-year smoking history + daily productive cough → strongly suggests **chronic obstructive pulmonary disease (COPD)** (Chunk 118).  \n- COPD (specifically emphysema, a subtype linked to smoking) is characterized by destruction of alveolar walls, leading to loss of elastic recoil and **increased lung compliance** (Chunk 1107).  \n\nCyclothymic disorder (Chunk 1106) is a mood disorder and irrelevant to lung pathology.  \n\n**Answer: Increased lung compliance**",
    "expected_answer": "Reid Index > 50%",
    "time": 8.852414846420288,
    "answer_length": 635,
    "retrieval_time": 0.03963017463684082,
    "generation_time": 8.823767185211182
  },
  {
    "question": "A 54-year-old male makes an appointment with his primary care physician due to chronic fatigue that has left him unable to hike or do other physically demanding activities with his friends. He has well-controlled hypertension and diabetes but has otherwise been healthy. He does not smoke but drinks socially with his friends. Physical exam reveals enlarged nodules that are not tender to palpation. A biopsy is obtained showing a characteristic change in chromosome 18. The regulation of which of the following proteins will be most abnormal in this patient?",
    "answer": "To answer this question, we analyze the provided information and link it to the key details in the question:\n\n\n### Step 1: Identify the patient’s condition  \nThe patient presents with chronic fatigue, enlarged non-tender nodules, and a biopsy showing a characteristic chromosome 18 change. From the provided chunks, **Waldenstrom’s macroglobulinemia (Chunk 820)** is a relevant condition (a lymphoplasmacytic lymphoma with monoclonal IgM secretion, often associated with genetic abnormalities).  \n\n\n### Step 2: Match to the protein in the chunks  \nThe question asks for the protein with abnormal regulation. Among the chunks, only **Chunk 1165** mentions a protein: \"Abnormal CFTR protein\".  \n\n\n### Conclusion  \nThe only protein referenced in the provided information is CFTR, so it is the answer.\n\n\nAnswer: CFTR protein (from Chunk 1165)  \n\n\\boxed{CFTR protein}",
    "expected_answer": "Caspase-9",
    "time": 17.433037757873535,
    "answer_length": 862,
    "retrieval_time": 0.1282517910003662,
    "generation_time": 17.4048330783844
  },
  {
    "question": "A 44-year-old African-American woman comes to the physician for a routine examination. She is concerned about cancer because her uncle died of metastatic melanoma 1 year ago. She has no history of serious illness and does not take any medication. She has been working in a law firm for the past 20 years and travels to the Carribean regularly with her husband. Examination of her skin shows no abnormal moles or warts. This woman is at greatest risk of which of the following types of melanoma?",
    "answer": "To determine the greatest risk of melanoma type in this patient, we focus on key clinical details and known melanoma epidemiology:\n\n\n### Key Patient Features:  \n- **African-American race**: A critical factor, as melanoma subtypes vary by skin tone.  \n- **No abnormal moles**: Rules out superficial spreading melanoma (linked to atypical moles) or lentigo maligna (linked to sun-damaged, freckled skin).  \n- **Sun exposure (Caribbean travel)**: Less relevant for the most common subtype in darker skin.  \n\n\n### Melanoma Subtype Prevalence in African Americans:  \nAcral lentiginous melanoma (ALM) accounts for ~70% of melanoma cases in African Americans (vs. ~5% in Caucasians). It arises on non-sun-exposed acral sites (palms, soles, nail beds) and is the most common subtype in individuals with darker skin tones, regardless of sun exposure.  \n\n\n**Answer: Acral lentiginous melanoma**\n\n\n\\boxed{Acral lentiginous melanoma}",
    "expected_answer": "Acral lentiginous",
    "time": 16.512120008468628,
    "answer_length": 921,
    "retrieval_time": 0.054712772369384766,
    "generation_time": 16.493600130081177
  },
  {
    "question": "A 60-year-old woman is brought to the clinic by her daughter for evaluation. The daughter reports that her mother has recently been having difficulty combing her hair in the mornings. The patient’s family history is significant for an ischemic stroke in her father. The patient’s past medical history is positive for diverticulosis. She takes no medication. Her blood pressure is 120/70 mm Hg, heart rate is 75/min, respiratory rate is 14/min, and temperature is 37.6°C (99.7°F). On physical examination, the patient’s neck is stiff and she also has bilateral shoulder tenderness; muscle strength is intact. Laboratory work is performed and presented below:\nHemoglobin 12.9 g/dL\nHematocrit 37.7% \nLeukocyte count 5,500/mm3\nNeutrophils 65%\nLymphocytes 30%\nMonocytes 5%\nMean corpuscular volume 82.2 μm3\nPlatelet count 190,000/mm3\nErythrocyte sedimentation rate 65 mm/h\nC-reactive protein 44 mg/dL\nFor which of the symptoms below should the patient be screened?",
    "answer": "To determine the symptom the patient should be screened for, we first identify her underlying condition:\n\n\n### Step 1: Diagnose the patient’s condition  \nThe patient (60-year-old woman) presents with:  \n- Bilateral shoulder tenderness/stiffness (difficulty combing hair = morning shoulder girdle stiffness)  \n- Neck stiffness  \n- Markedly elevated inflammatory markers (ESR 65 mm/h, CRP 44 mg/dL)  \n- Normal muscle strength and blood cell counts  \n\nThese findings are classic for **polymyalgia rheumatica (PMR)**, an inflammatory disorder affecting adults >50 years, characterized by proximal girdle pain/stiffness and elevated inflammatory markers.\n\n\n### Step 2: Key association with PMR  \nPMR is strongly linked to **giant cell arteritis (GCA, temporal arteritis)**, a vasculitis that can cause irreversible vision loss if untreated. Up to 50% of PMR patients have GCA, so screening for GCA symptoms is critical.\n\n\n### Step 3: Symptoms to screen for  \nCommon GCA symptoms include:  \n- Temporal headache  \n- Jaw claudication (pain with chewing)  \n- Visual disturbances (e.g., blurred vision, amaurosis fugax)  \n\nAmong these, **jaw claudication** is a highly specific symptom of GCA and a priority for screening.\n\n\n**Answer: Jaw claudication** (or visual disturbances like amaurosis fugax; jaw claudication is a classic screening target).  \n\n(Note: If options included visual symptoms, those are also correct, but jaw claudication is a common key answer here.)\n\n\n\\boxed{Jaw claudication}",
    "expected_answer": "Jaw claudication",
    "time": 28.233821153640747,
    "answer_length": 1487,
    "retrieval_time": 0.059227943420410156,
    "generation_time": 28.214663982391357
  },
  {
    "question": "A 30-year-old woman comes to the physician because she has been unable to conceive for 3 years. Analysis of her husband's semen has shown normal sperm counts during this time. The patient also reports episodic pelvic and back pain accompanied by painful diarrhea for 5 years. She has about one such episode on average per month for 4–6 days. She has taken ibuprofen for the pain, which has provided some relief. Menses have occurred at regular 29-day intervals since menarche at the age of 14 years and last for 7 days. She is sexually active with her husband and does not use contraception. Vital signs are within normal limits. Pelvic and bimanual examinations are normal; rectal examination is unremarkable. A hysterosalpingogram 6 months prior showed normal results. Which of the following is the most likely underlying mechanism of this patient's symptoms?",
    "answer": "To determine the underlying mechanism of the patient’s symptoms, we analyze her key findings and match them to the provided chunks:\n\n\n### **Patient Key Findings**  \n- **Primary infertility**: 3 years, husband’s semen normal, HSG (tubal patency) normal.  \n- **Cyclic symptoms**: Monthly pelvic/back pain + painful diarrhea (4-6 days/month), responsive to ibuprofen (NSAID).  \n- **Normal exams**: Pelvic/bimanual/rectal exams unremarkable.  \n\n\n### **Analysis of Chunks**  \n- **Chunk8 (PID)**: Unlikely—PID causes non-cyclic pain, abnormal discharge, and often tubal blockage (HSG normal here).  \n- **Chunk223 (Prostaglandin-mediated endometrial sloughing/uterine contractions)**: Fits. The cyclic pain and diarrhea are due to prostaglandins:  \n  - Prostaglandins are released during menstrual cycles (and ectopic endometrial activity, e.g., endometriosis) → stimulate uterine contractions (pelvic pain) and GI smooth muscle (diarrhea).  \n  - Ibuprofen (NSAID) blocks prostaglandin synthesis, explaining symptom relief.  \n- **Chunk44 (10-week uterus)**: Irrelevant—no mention of abnormal uterine size.  \n- **Chunk45 (Fomepizole)**: Unrelated (antidote for methanol poisoning).  \n\n\n**Answer: Endometrial sloughing and uterine contractions mediated by prostaglandin** (Chunk223)  \n\n\\boxed{Endometrial sloughing and uterine contractions mediated by prostaglandin}",
    "expected_answer": "Endometrial tissue outside the uterine cavity",
    "time": 42.52464318275452,
    "answer_length": 1357,
    "retrieval_time": 0.0488431453704834,
    "generation_time": 42.50034999847412
  },
  {
    "question": "A 55-year-old truck driver is brought to a physician by his wife. She states that her husband developed a fever and began feeling weak 3 days ago, but has refused medical help. He has been unable to go to work because of his symptoms. The patient has been previously hospitalized for a tricuspid valve replacement surgery 1 year ago and takes aspirin daily. The medical history is also relevant for myocardial infarction 3 years ago and hypertension for the past 10 years, for which he takes lisinopril. His blood pressure is 140/80 mm Hg, the pulse is 82/min, the respirations are 18/minute, and the temperature is 37.2°C (98.9°F). On examination, several hemorrhages are noted on the nail beds of several fingers. Which of the following findings would be most helpful in establishing a diagnosis?",
    "answer": "To establish the diagnosis in this patient, the most helpful finding from the provided information is **liquefactive necrosis** (Chunk 830).  \n\n### Key Reasoning:  \nThe patient’s clinical profile (prosthetic tricuspid valve replacement, fever, weakness, nail bed hemorrhages [splinter hemorrhages]) strongly suggests **infective endocarditis (IE)**. A classic complication of IE (especially prosthetic valve IE) is the formation of abscesses (e.g., valve ring abscesses), which are characterized by liquefactive necrosis. This finding directly supports the diagnosis of IE by confirming endocardial involvement (a major Duke criterion for IE).  \n\nOther provided chunks (Raynaud’s phenomenon, parvovirus B19 serology) are irrelevant to the patient’s presentation: Raynaud’s is vasospasm unrelated to IE, and parvovirus B19 does not cause the observed features of IE.  \n\n**Answer: Liquefactive necrosis** (from Chunk 830).  \n\n\\boxed{Liquefactive necrosis}",
    "expected_answer": "Friable irregular masses attached to the valve",
    "time": 36.13673973083496,
    "answer_length": 953,
    "retrieval_time": 0.049806833267211914,
    "generation_time": 36.115896224975586
  },
  {
    "question": "A previously healthy 30-year-old woman comes to the physician for the evaluation of pain during sexual intercourse for 6 months. She also reports frequent episodes of crampy pelvic pain that starts one day before menses and lasts for 7 days. Her symptoms are not relieved with pain medication. Menses occur at regular 28-day intervals and last 5 days. Her last menstrual period was 2 weeks ago. She is sexually active with her husband. She uses a combined oral contraceptive pill. Her vital signs are within normal limits. Physical examination shows rectovaginal tenderness. Cervical and urethral swabs are negative. Transvaginal ultrasonography shows no abnormalities. Which of the following is the most appropriate next step in management?",
    "answer": "To determine the most appropriate next step, we first analyze the patient’s clinical presentation and rule out key differential diagnoses:\n\n\n### **Key Clinical Findings**  \n- **Chronic symptoms**: 6 months of dyspareunia (painful intercourse) and crampy pelvic pain (premenstrual + during menses) unresponsive to pain meds.  \n- **Exam/Tests**: Rectovaginal tenderness (classic for endometriosis), negative cervical/urethral swabs (rules out Chlamydia trachomatis, a leading cause of PID), normal transvaginal ultrasound (no structural abnormalities like endometriomas, fibroids, or cysts).  \n- **No acute infection**: Vital signs normal (excludes active PID).  \n\n\n### **Likely Diagnosis**  \n**Endometriosis**: This aligns with her persistent dyspareunia, dysmenorrhea unresponsive to meds, rectovaginal tenderness, and normal imaging (small endometriosis lesions are often invisible on ultrasound).  \n\n\n### **Next Step in Management**  \nFor suspected endometriosis with normal imaging and persistent symptoms despite combined oral contraceptives (COCPs), the **gold standard for diagnosis** is **diagnostic laparoscopy** to visualize and biopsy endometriotic lesions.  \n\n\n**Answer**: Diagnostic laparoscopy.  \n\n(Note: If this was an option in the original question, it is the correct next step given the clinical context.)\n\n\n\\boxed{Diagnostic laparoscopy}",
    "expected_answer": "Laparoscopy",
    "time": 34.06657409667969,
    "answer_length": 1355,
    "retrieval_time": 0.3096930980682373,
    "generation_time": 34.04673910140991
  },
  {
    "question": "A 50-year-old man visits his physician after 20 years of not seeking any medical care. He is concerned about his health after a colleague recently had a heart attack. The patient has no active complaints and says he feels healthy; however, he does not exercise regularly and lives a sedentary lifestyle. He is employed as an administrative position at a local college, and is seated at a desk most of the day. His father had a heart attack at age 54 and his mother is still alive with no health concerns. He does not smoke, only drinks socially, and does not use drugs. Today, his blood pressure is 130/90 mm Hg, pulse is 84/min, and respiratory rate is 14/min. Physical examination reveals an obese male with no significant findings. An ECG shows no abnormalities, and laboratory testing shows the following:\nLaboratory test\nSerum glucose (fasting)  105 mg/dL\nSerum electrolytes \nSodium  142 mEq/L\nPotassium 3.9 mEq/L\nChloride 101 mEq/L\nSerum creatinine 0.8 mg/dl\nBlood urea nitrogen 10 mg/dl\nCholesterol, total 250 mg/dL\nHDL-cholesterol 35 mg/dL\nLDL-cholesterol 186 mg/dL\nTriglycerides 170 mg/dL\nUrinalysis \nGlucose  negative\nKetones negative\nLeucocytes negative\nNitrites negative \nRed blood cells (RBC) negative \nCasts negative \nWhich of the following lab abnormalities in this patient is an indication for treatment?",
    "answer": "To determine which lab abnormality indicates treatment, we analyze the patient’s results and their clinical context:\n\n\n### Key Lab Abnormalities & Clinical Context  \nThe patient is a 50-year-old male with **elevated ASCVD (atherosclerotic cardiovascular disease) risk factors**:  \n- Sedentary lifestyle, obesity  \n- Family history of premature CAD (father had heart attack at age 54, <55 years old)  \n- Abnormal lipid profile  \n\n\n### Normal vs. Abnormal Lab Values & Treatment Indications  \n1. **Fasting glucose (105 mg/dL)**: Prediabetes (<100 normal; 100-125 prediabetes). Initial management is lifestyle modifications (diet/exercise), not medication (metformin is considered only if additional high-risk factors, not first-line here).  \n\n2. **Total cholesterol (250 mg/dL)**: High (>240), but LDL is the primary target for lipid-lowering therapy.  \n\n3. **HDL (35 mg/dL)**: Low (<40 for men), but HDL elevation is not a direct medication target (statins modestly raise HDL, but LDL is prioritized).  \n\n4. **LDL (186 mg/dL)**: Very high. For patients with elevated ASCVD risk (like this patient), LDL levels >190 (or in this case, with 10-year risk ≥7.5%) warrant statin therapy. His risk factors (family history, obesity, age) make his 10-year ASCVD risk >7.5%, so statin treatment is indicated.  \n\n5. **Triglycerides (170 mg/dL)**: Borderline (150-199), managed with lifestyle first.  \n\n\n**Answer: LDL-cholesterol 186 mg/dL** (or total cholesterol 250 mg/dL, but LDL is the primary target; given standard exam questions, LDL is the expected answer).  \n\n\\boxed{LDL-cholesterol 186 mg/dL}",
    "expected_answer": "High LDL-cholesterol",
    "time": 28.330095052719116,
    "answer_length": 1589,
    "retrieval_time": 0.05042004585266113,
    "generation_time": 28.31175708770752
  },
  {
    "question": "A 26-year-old woman is brought to the emergency department 20 minutes after being involved in a high-speed motor vehicle collision in which she was a restrained passenger. On arrival, she is lethargic and incoherent. She has severe facial lacerations and is in respiratory distress. Her pulse is 130/min, respirations are 29/min, and blood pressure is 90/58 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 70%. Examination shows multiple facial lacerations. There is dullness to percussion and decreased breath sounds over the left lung base. Abdominal examination shows diffuse tenderness with no guarding or rebound. Bowel sounds are normal. The remainder of the examination shows no abnormalities. Her hemoglobin concentration is 12.1 g/dL. An x-ray of the chest shows a fractured left second rib, depression of the left mainstem bronchus, deviation of the nasogastric tube to the right, and a widened mediastinum. Which of the following is the most likely diagnosis?",
    "answer": "To determine the most likely diagnosis, we analyze the key clinical and radiological findings in the context of a high-speed motor vehicle collision (MVA):\n\n\n### **Key Findings**  \n- **Mechanism**: High-speed MVA (restrained passenger → deceleration injury).  \n- **Vitals**: Tachycardia (130/min), hypotension (90/58 mmHg), hypoxemia (70% O₂ sat), respiratory distress.  \n- **Chest X-ray**: Widened mediastinum, fractured left 2nd rib, NG tube deviation to the right, left mainstem bronchus depression.  \n- **Examination**: Left lung base dullness/decreased breath sounds (possible associated hemothorax), but no massive anemia (Hb=12.1 g/dL, early injury).  \n\n\n### **Classic Association**  \nTraumatic aortic injury (TAI) is strongly linked to **deceleration injuries** (restrained passengers in high-speed MVAs). The chest X-ray findings here are pathognomonic for TAI:  \n- **Widened mediastinum**: Shear forces at the ligamentum arteriosum (aortic attachment) cause aortic tears.  \n- **Rightward NG tube/tracheal deviation**: Displacement of mediastinal structures.  \n- **Fractured 1st/2nd ribs**: Near the aortic arch, often associated with TAI.  \n- **Left mainstem bronchus depression**: Secondary to mediastinal shift.  \n\n\n### **Differential Exclusions**  \n- **Hemothorax**: Explains dullness but not widened mediastinum or NG tube deviation.  \n- **Pneumothorax**: Hyperresonance (not dullness) and no widened mediastinum.  \n- **Cardiac tamponade**: No jugular venous distension or distant heart sounds.  \n\n\n**Answer: Traumatic aortic rupture (or traumatic aortic injury)**\n\n\n\\boxed{Traumatic aortic rupture}",
    "expected_answer": "Thoracic aortic rupture",
    "time": 30.28439712524414,
    "answer_length": 1613,
    "retrieval_time": 0.051419973373413086,
    "generation_time": 30.268669843673706
  },
  {
    "question": "A 26-year-old G1P0 woman presents to her primary care physician’s office with feelings of anxiety and trouble with sleep. She finds it difficult initiating sleep, occasionally has palpitations, and feels fatigued. She denies having similar symptoms in the past or starting any new medications or illicit drugs. She is currently 10 weeks pregnant and is closely followed by her obstetrician. Her temperature is 98.6°F (37°C), blood pressure is 125/70 mmHg, pulse is 105/min, and respirations are 18/min. On physical exam, the patient is mildly diaphoretic. The skin is warm and the thyroid gland is diffusely enlarged with thyroid bruits. Laboratory studies are significant for a thyroid-stimulating hormone level of 0.01 µU/mL (normal is 0.5-5.0 µU/mL) and an elevated free thyroxine (FT4) that is inappropriate for her pregnancy. Which of the following is the best treatment option for this patient?",
    "answer": "To determine the best treatment option, we first analyze the case and then apply key guidelines for hyperthyroidism in pregnancy:\n\n\n### **Step 1: Diagnosis**  \nThe patient presents with **hyperthyroidism** (anxiety, palpitations, diaphoresis, warm skin, low TSH [0.01 µU/mL], elevated FT4) plus a diffuse goiter with bruits—classic for **Graves disease** (the most common cause of hyperthyroidism in pregnancy).\n\n\n### **Step 2: Treatment Guidelines for Graves Disease in Pregnancy**  \n- **Radioactive iodine**: Contraindicated (crosses placenta, damages fetal thyroid).  \n- **Surgery**: Reserved for ATD intolerance/contraindications; safest in the second trimester (not first-line here).  \n- **Antithyroid drugs (ATDs)**: First-line.  \n  - **First trimester**: Prefer **Propylthiouracil (PTU)** because methimazole (MMI) has higher risk of congenital anomalies (e.g., aplasia cutis, esophageal atresia).  \n  - **Second/third trimesters**: Switch to MMI to avoid PTU’s risk of fulminant hepatotoxicity.  \n\n\n### **Step 3: Application to the Case**  \nThe patient is at **10 weeks gestation** (first trimester). Thus, the best treatment is PTU.\n\n\n**Answer: Propylthiouracil** (PTU) is the best treatment option.  \n\n(Note: If the option list included PTU, that would be the correct choice. Since the question expects a specific answer based on standard guidelines, PTU is the answer.)  \n\n\\boxed{Propylthiouracil}",
    "expected_answer": "Propylthiouracil",
    "time": 16.397679090499878,
    "answer_length": 1408,
    "retrieval_time": 0.060096025466918945,
    "generation_time": 16.380491971969604
  },
  {
    "question": "A 32-year-old woman comes to the physician because of a 3-week history of intermittent loose stools and a 1.2-kg (2.6-lb) weight loss. She immigrated to the US from Uganda 6 weeks ago. Abdominal examination shows diffuse tenderness with no guarding or rebound. The liver is firm and palpable 3 cm below the right costal margin, and the spleen is palpable just below the left costal margin. Her leukocyte count is 12,800/mm3 (12% eosinophils). Stool culture shows several oval-shaped eggs with lateral spines. Microscopic examination of a liver biopsy specimen shows granulomatous inflammation with periportal fibrosis. Exposure to which of the following is most likely to have played a role in the development of this patient's symptoms?",
    "answer": "To determine the likely exposure, we first analyze the patient’s clinical and laboratory findings, which strongly point to **Schistosoma mansoni infection**:\n\n\n### Key Clues:\n- **Egg morphology**: Oval eggs with lateral spines (pathognomonic for *S. mansoni*).  \n- **Endemic region**: Uganda (where *S. mansoni* is prevalent).  \n- **Symptoms/signs**:  \n  - Intestinal involvement: Loose stools, weight loss (colon is targeted by *S. mansoni*).  \n  - Hepatic/splenic involvement: Firm liver (3cm below costal margin), palpable spleen (due to periportal granulomas → pipestem fibrosis → portal hypertension).  \n  - Eosinophilia (12%): Typical for helminth infections (immune response to parasite larvae/eggs).  \n\n\n### Schistosoma Transmission:\n*S. mansoni* spreads via **contact with contaminated freshwater** (e.g., swimming, wading in rivers/lakes). Cercariae (larval stage released by snails, the intermediate host) penetrate human skin to initiate infection.\n\n\n**Answer: Exposure to contaminated freshwater.** (Note: If options were provided, this would align with choices like \"Freshwater swimming in an endemic area.\")",
    "expected_answer": "Freshwater snails",
    "time": 23.13239097595215,
    "answer_length": 1122,
    "retrieval_time": 0.041433095932006836,
    "generation_time": 23.115185022354126
  },
  {
    "question": "A 3-month-old girl is brought to a pediatrician by her parents. She has central cyanosis without signs of respiratory distress or signs of heart failure. An echocardiogram reveals severe pulmonary outflow obstruction, right ventricular hypertrophy, a ventricular septal defect, and an overriding of the aorta. An elective primary surgical repair is planned at 4 months of age. Which of the following statements is true about this girl’s condition?",
    "answer": "The true statement about the girl’s condition relates to **increased ventricular wall stiffness** (Chunk 31).  \n\nThe patient’s clinical and echocardiographic findings (central cyanosis, severe pulmonary outflow obstruction, right ventricular hypertrophy [RVH], ventricular septal defect, overriding aorta) are consistent with **Tetralogy of Fallot (TOF)**. A key feature of TOF is right ventricular hypertrophy, which leads to increased ventricular wall stiffness (as noted in Chunk 31). This stiffness arises from the thickened ventricular wall due to chronic pressure overload from the pulmonary outflow obstruction.  \n\nOther provided chunks are irrelevant: Chunk 30 (cystic duct obstruction) involves biliary tract issues, and Chunk 1076 (informed consent inquiry) does not apply to this pediatric cardiac condition.  \n\n**Answer:** The girl’s condition is associated with increased ventricular wall stiffness. (Or, if framed as a statement from options, this would be the correct choice.)",
    "expected_answer": "Normal hemoglobin in patients with tetralogy of Fallot does not rule out iron deficiency anemia.",
    "time": 24.863908290863037,
    "answer_length": 991,
    "retrieval_time": 0.13736796379089355,
    "generation_time": 24.835241079330444
  },
  {
    "question": "Six days after undergoing surgical repair of a hip fracture, a previously healthy 79-year-old woman is agitated and confused. She is unarousable during the day, but then is awake and impulsive during the night, requiring frequent reorientation. Her husband says that she usually drinks one to two glasses of wine weekly. Her only current medication is oxycodone for pain. Her vital signs are within normal limits. She is distressed and oriented to person but not to place or time. Neurologic examination shows inattentiveness but no focal deficits. Urine dipstick is normal. Which of the following is the most likely cause of her current condition?",
    "answer": "To determine the most likely cause of the patient’s condition, let’s analyze the scenario and connect it to key clinical insights:\n\n\n### Key Clinical Features  \nThe 79-year-old woman presents with **acute delirium** (agitation, confusion, day-night reversal, inattention, fluctuating consciousness) 6 days post-femoral neck fracture repair. She is taking oxycodone for pain, has no focal neurologic deficits, normal vital signs, and a normal urine dipstick. Her alcohol use (1-2 glasses weekly) is minimal and not consistent with alcohol use disorder.\n\n\n### Most Likely Cause  \nThe primary trigger here is **opioid-induced delirium** from oxycodone. Opioids are a well-documented cause of delirium in elderly patients, especially post-operatively, due to their central nervous system effects (sedation, cognitive impairment, and disruption of sleep-wake cycles).  \n\nNone of the provided chunks directly list this cause, but based on standard clinical reasoning for this scenario, the answer is:  \n\n**Opioid-induced delirium (secondary to oxycodone use)**\n\n\nAnswer: Opioid-induced delirium (from oxycodone)  \n(Note: This aligns with the classic presentation of post-operative delirium in elderly patients on opioids, even though it is not explicitly listed in the provided chunks.)",
    "expected_answer": "Delirium",
    "time": 36.24264597892761,
    "answer_length": 1280,
    "retrieval_time": 0.042205810546875,
    "generation_time": 36.21745014190674
  },
  {
    "question": "A 54-year-old woman with a past medical history of mental retardation, hypertension, and diabetes presents to the emergency department with a change in her behavior. Her caretakers state that the patient’s gait suddenly became ataxic, and she became less responsive than her normal non-verbal baseline. Her temperature is 98.5°F (36.9°C), blood pressure is 125/68 mmHg, pulse is 90/min, respirations are 15/min, and oxygen saturation is 99% on room air. Physical exam is notable for an unremarkable HEENT exam with normal facial features and no signs of airway compromise. Neurological exam is remarkable for new onset spasticity. The patient has 3+ reflexes and a positive Babinski sign. Musculoskeletal exam is only notable for symmetric swelling and deformities of the patient’s hands bilaterally. Additionally, there is a \"clunk\" when posterior force is applied to the head while anterior force is applied to the cervical spine. Which of the following is the most likely risk factor that predisposed this patient to this condition?",
    "answer": "To answer this question, we first identify the patient’s condition and then its underlying risk factor:\n\n\n### Step 1: Diagnose the Patient’s Condition  \nThe patient presents with:  \n- **Upper motor neuron (UMN) signs**: New spasticity, 3+ reflexes, positive Babinski sign (indicates spinal cord involvement).  \n- **Ataxic gait**: Suggests cervical cord dysfunction (coordination tracts are in the cervical region).  \n- **\"Clunk\" sign**: Posterior force on the head + anterior force on the cervical spine (Atlantoaxial Instability [AAI]—instability between C1 and C2 vertebrae).  \n- **Mental retardation**: A key clue for Down syndrome.  \n\nThese findings point to **cervical myelopathy secondary to Atlantoaxial Instability (AAI)**.  \n\n\n### Step 2: Identify the Predisposing Risk Factor  \nAAI is strongly associated with **Down syndrome** (trisomy 21), a condition marked by mental retardation, ligamentous laxity, and bony abnormalities of the cervical spine. This is the most likely risk factor given the patient’s mental retardation and AAI.  \n\n\n**Answer: Down syndrome** (or if framed as the marker, mental retardation—though Down syndrome is the underlying risk factor).  \n\nNote: The provided chunks (138,139,1019) are not directly relevant to this conclusion, as the question’s clinical details alone suffice to identify the condition and risk factor.\n\n\n\\boxed{Down syndrome}",
    "expected_answer": "Rheumatoid arthritis",
    "time": 33.02848219871521,
    "answer_length": 1380,
    "retrieval_time": 0.04898428916931152,
    "generation_time": 33.0007541179657
  },
  {
    "question": "A 24-year-old man is brought to the emergency department 15 minutes after he sustained a stab wound to the left chest just below the clavicle. On arrival, he has rapid, shallow breathing and appears anxious. His pulse is 135/min, respirations are 30/min and shallow, and palpable systolic blood pressure is 80 mm Hg. He is intubated and mechanically ventilated. Infusion of 0.9% saline is begun. Five minutes later, his pulse is 133/min and blood pressure is 82/45 mm Hg. Examination shows no active external bleeding. There is a 2.5-cm single stab wound to the left chest at the 4th intercostal space at the midclavicular line. Cardiovascular examination shows muffled heart sounds and jugular venous distention. Breath sounds are normal. Further evaluation of this patient is most likely to show which of the following findings?",
    "answer": "To determine the most likely finding, we analyze the patient’s clinical presentation and connect it to the provided information:\n\n\n### Step 1: Identify the clinical syndrome  \nThe patient has a stab wound to the left chest, with **Beck’s triad**:  \n- Muffled heart sounds  \n- Jugular venous distention (JVD)  \n- Hypotension (persistent despite fluid resuscitation)  \n\nThese are classic signs of **cardiac tamponade** (fluid accumulation in the pericardial space compressing the heart, impairing ventricular filling).\n\n\n### Step 2: Key finding in cardiac tamponade  \nA hallmark of cardiac tamponade is **pulsus paradoxus**—a drop in systolic blood pressure ≥10 mmHg during inspiration.  \n\nChunk 94 explicitly states: \"A drop in systolic blood pressure of 14 mmHg during inspiration\"—this aligns with pulsus paradoxus.\n\n\n**Answer:** A drop in systolic blood pressure of 14 mmHg during inspiration.",
    "expected_answer": "A drop in systolic blood pressure of 14 mmHg during inspiration",
    "time": 16.51676630973816,
    "answer_length": 895,
    "retrieval_time": 0.04639410972595215,
    "generation_time": 16.4868061542511
  },
  {
    "question": "A 40-year-old man presents to his primary-care doctor for a follow-up of his hypertension. He is asymptomatic at his office visit and denies any new complaints. He has a 10-year history of hypertension that remains poorly controlled on maximum doses of lisinopril, hydrochlorothiazide, and amlodipine. His past medical history is otherwise unremarkable. He has no smoking history, drinks alcohol occasionally, and denies any illicit drug use. His father required a kidney transplant in his forties. The physical exam is notable for palpable flank masses bilaterally. Laboratory studies show a creatinine of 2.5. The physician orders a renal ultrasound, and the results are shown. Which of the following is the most appropriate test to screen for additional complications of this patient's condition?",
    "answer": "To answer this question, we first identify the patient’s condition and then determine the key complication requiring screening.\n\n\n### Step 1: Diagnose the Patient’s Condition  \nThe patient’s key features are:  \n- 40-year-old man with long-standing, poorly controlled hypertension (despite 3 medications).  \n- Palpable bilateral flank masses.  \n- Elevated creatinine (2.5, indicating renal impairment).  \n- Family history of kidney transplant in his father (age 40s).  \n\nThese findings are classic for **autosomal dominant polycystic kidney disease (ADPKD)**—a genetic disorder characterized by bilateral renal cysts, hypertension, renal failure, and extra-renal complications.\n\n\n### Step 2: Identify Critical Additional Complications of ADPKD  \nADPKD’s most life-threatening extra-renal complication is **intracranial berry aneurysms** (rupture causes subarachnoid hemorrhage, a leading cause of death in ADPKD patients). Screening is recommended for patients with family history of aneurysmal bleeding or those at high risk (e.g., planned surgery/anesthesia).\n\n\n### Step 3: Choose the Appropriate Screening Test  \nThe gold standard non-invasive test for screening intracranial aneurysms is **magnetic resonance angiography (MRA) of the brain**—it avoids radiation and contrast-related renal harm (important here, given the patient’s renal impairment).\n\n\n**Answer: Magnetic resonance angiography (MRA) of the brain**  \n\n(Note: If this option was not explicitly listed, but common alternatives like CT angiography are excluded due to contrast/radiation risks, MRA remains the optimal choice.)  \n\nFinal Answer  \n\\boxed{Magnetic resonance angiography of the brain}",
    "expected_answer": "MR angiography of the brain",
    "time": 21.959758758544922,
    "answer_length": 1661,
    "retrieval_time": 0.0386507511138916,
    "generation_time": 21.941761016845703
  },
  {
    "question": "A 17-year-old female is brought to the emergency room by her father because she has been experiencing shortness of breath and chest pain. She says that the chest pain is worse when she breathes or coughs. Furthermore, on the way to the hospital she noticed that there were specks of blood on a tissue that she coughed into. She has no previous medical history and does not recall anything that could have provoked these symptoms. On presentation her temperature is 99°F (37.2°C), blood pressure is 107/65 mmHg, pulse is 102/min, respirations are 21/min, and O2 saturation is 91% on room air. Further testing shows a large filling defect in the pulmonary vessels, and the patient is started on an appropriate treatment intravenously. After drug administration, the effects of the drug are monitored using a standard blood test. Surprisingly, the test results come back within normal parameters. The most likely underlying cause of this patient's symptoms has which of the following modes of inheritance?",
    "answer": "To answer this question, we first identify the patient’s condition and its underlying cause, then determine the mode of inheritance.\n\n\n### Step 1: Diagnose the patient’s acute condition  \nThe patient presents with **shortness of breath, pleuritic chest pain, hemoptysis**, and a **large filling defect in pulmonary vessels**—classic for **pulmonary embolism (PE)**.  \n\nShe is treated with IV heparin (standard initial therapy for PE). Heparin’s effects are monitored via the **aPTT** test, but her aPTT remains normal despite treatment. This suggests heparin resistance, which is a hallmark of **antithrombin deficiency** (heparin works by potentiating antithrombin; without sufficient antithrombin, heparin has no effect on aPTT).  \n\n\n### Step 2: Mode of inheritance of antithrombin deficiency  \nAntithrombin deficiency is an **autosomal dominant** disorder. It causes a hypercoagulable state, increasing the risk of venous thromboembolism (like PE) in young patients with no other risk factors.  \n\n\n**Answer: Autosomal dominant**",
    "expected_answer": "Autosomal dominant",
    "time": 15.00467824935913,
    "answer_length": 1031,
    "retrieval_time": 0.10800695419311523,
    "generation_time": 14.975612878799438
  },
  {
    "question": "A 26-year-old male presents to his primary care physician with complaints of burning with urination, penile discharge, and intermittent fevers. A urethral smear shows gram negative diplococci within white blood cells. The organism grows well when cultured on Thayer-Martin agar. The patient is prescribed a course of ceftriaxone and the infection resolves without further complication. One year later, the patient returns with the same infection. Which of the following best explains this lack of lasting immunity?",
    "answer": "To determine why there is no lasting immunity to this infection, we first identify the organism:  \n\n### Step 1: Identify the pathogen  \nThe patient’s symptoms (burning urination, penile discharge, fevers), gram-negative diplococci within white blood cells, and growth on Thayer-Martin agar (selective for *Neisseria* species) confirm the infection is **Neisseria gonorrhoeae** (gonorrhea).  \n\n\n### Step 2: Key reason for lack of lasting immunity  \n*N. gonorrhoeae* evades the immune system via **antigenic variation** of its surface structures, specifically:  \n- **Pili**: Critical for adhesion to host cells; the bacteria switches genes encoding pilin proteins, generating new variants unrecognized by prior antibodies.  \n- **Outer membrane proteins (Opa proteins)**: Also undergo antigenic variation, further escaping immune detection.  \n\nThis constant change in surface antigens prevents the host from developing long-term protective immunity, allowing reinfection even after successful treatment.  \n\n\n**Answer:** Antigenic variation of surface proteins (e.g., pili, Opa proteins) by *Neisseria gonorrhoeae* evades the host immune response, precluding lasting immunity.  \n\n(Note: If the question expects a concise phrase, it would likely be \"Antigenic variation of the pathogen’s surface antigens.\")  \n\nFinal Answer: Antigenic variation of surface proteins (pili and Opa proteins) in Neisseria gonorrhoeae.  \n\\boxed{Antigenic variation of surface proteins of Neisseria gonorrhoeae}",
    "expected_answer": "Antigenic variation",
    "time": 16.901514053344727,
    "answer_length": 1484,
    "retrieval_time": 0.04235100746154785,
    "generation_time": 16.886667013168335
  },
  {
    "question": "A 37-year-old man with no significant past medical history is rear-ended in a motor vehicle accident. He reported significant neck pain to emergency responders, but otherwise denies weakness, numbness or tingling in his extremities. His vitals on presentation to the ED are HR 90, BP 140/80, RR 20, SpO2 98%. What is the most appropriate next step upon presentation to the emergency room?",
    "answer": "The most appropriate next step is ultrasonography of the neck.  \n\nThe patient presents with significant neck pain following a motor vehicle accident (rear-end collision) but no neurological deficits (weakness, numbness, tingling) and normal vital signs. Among the provided chunks, only Chunk 511 (Ultrasonography of the neck) is relevant to evaluating the neck pain from trauma. The other chunks (distributive shock, head MRI, DNR) do not apply to this stable patient with isolated neck pain after trauma.  \n\nAnswer: Ultrasonography of the neck (Chunk 511)",
    "expected_answer": "Cervical immobilization",
    "time": 10.12426495552063,
    "answer_length": 556,
    "retrieval_time": 0.046234130859375,
    "generation_time": 10.110970258712769
  },
  {
    "question": "A 43-year-old man with a history of schizophrenia, currently controlled with medication, comes in for an appointment with his internist. He is concerned about abnormal discharge from both nipples over the past 3 months. The fluid is white, and he wonders if it could be milk. On further review of systems, he endorses a diminished sexual drive. The physician suspects that one of the patient's medications may be the culprit for these symptoms. Which of the following medications is NOT likely to be the cause?",
    "answer": "To determine which medication is NOT likely the cause of the patient’s symptoms (galactorrhea and diminished libido, indicative of hyperprolactinemia), we analyze the options:\n\n\n### Key Background  \nHyperprolactinemia arises when dopamine (which inhibits prolactin) is reduced. Antipsychotics (used for schizophrenia) often block dopamine, causing this issue. We need to identify which drug does NOT contribute to hyperprolactinemia.\n\n\n### Analysis of Chunks  \n- **Chunk 252 (Methylphenidate):** A stimulant (dopamine reuptake inhibitor) that increases dopamine levels. Higher dopamine suppresses prolactin, so it cannot cause hyperprolactinemia.  \n- **Chunk 451 (Phosphodiesterase inhibitor):** E.g., sildenafil (Viagra). It does not affect dopamine or prolactin directly, but the question asks for the medication NOT likely the cause—methylphenidate is a clearer answer.  \n- **Other chunks:** Are either non-medications (isolated GnRH deficiency, hydrocele) or unrelated to hyperprolactinemia (dexamethasone/epinephrine for croup).  \n\n\n**Answer:** Chunk 252 (Methylphenidate)  \n\n\\boxed{252}",
    "expected_answer": "Bromocriptine",
    "time": 25.724782705307007,
    "answer_length": 1092,
    "retrieval_time": 0.07476806640625,
    "generation_time": 25.70861792564392
  }
]